ApoE4-dependent lysosomal cholesterol accumulation impairs mitochondrial homeostasis and oxidative phosphorylation in human astrocytes
Open accessAbstract
Recent developments in genome sequencing have expanded the knowledge of genetic factors associated with late-onset Alzheimer's disease (AD). Among them, genetic variant ε4 of the APOE gene (APOE4) confers the greatest disease risk. Dysregulated glucose metabolism is an early pathological feature of AD. Using isogenic ApoE3 and ApoE4 astrocytes derived from human induced pluripotent stem cells, we find that ApoE4 increases glycolytic activity but impairs mitochondrial respiration in astrocytes. Ultrastructural and autophagy flux analyses show that ApoE4-induced cholesterol accumulation impairs lysosome-dependent removal of damaged mitochondria. Acute treatment with cholesterol-depleting agents restores autophagic activity, mitochondrial dynamics, and associated proteomes, and extended treatment rescues mitochondrial respiration in ApoE4 astrocytes. Taken together, our study provides a direct link between ApoE4-induced lysosomal cholesterol accumulation and abnormal oxidative phosphorylation.
AI snapshot
Written from the paper’s full text.
TL;DR
Using isogenic human iPSC-derived astrocytes, this study shows that ApoE4 increases glycolysis but impairs mitochondrial respiration and oxidative phosphorylation. ApoE4-dependent lysosomal cholesterol accumulation disrupts autophagy/mitophagy, and cholesterol depletion restores mitochondrial homeostasis and respiration but not glycolytic activity.
Key findings
- ApoE4 astrocytes showed increased glycolytic activity, including higher ECAR, increased lactate release, and increased m+3 lactate from 13C-glucose tracing, compared with isogenic ApoE3 astrocytes.
- ApoE4 astrocytes had reduced mitochondrial respiration: lower basal respiration, maximal respiration, ATP-linked respiration, and reserve capacity, with increased mitochondrial ROS by MitoSOX.
- ApoE4 astrocytes accumulated cholesterol predominantly in lysosomes, had enlarged lysosomes, increased LysoTracker area/intensity, and approximately 50% higher cathepsin B activity; they also showed impaired autophagy flux with increased p62/LC3 and increased autophagosomes but decreased autolysosomes.
- MβCD treatment (100 μM, 4 days) reduced lysosomal cholesterol and restored autophagy flux and mitochondrial ultrastructure; 14 days of MβCD restored mitochondrial respiration but did not normalize glycolytic activity. Proteomics found 254 downregulated and 238 upregulated proteins in ApoE4 astrocytes, with 16 downregulated and 34 upregulated proteins restored by MβCD.
Methods
- Isogenic ApoE3/ApoE4 human iPSC-derived astrocytes were generated from an AD patient-derived APOE4 line edited to APOE3 by CRISPR-Cas9, another healthy-individual-derived isogenic pair, and the KOLF2.1J reference line with isogenic ApoE4; astrocytes were differentiated, FACS-sorted by GLAST, and validated by astrocyte markers.
- Metabolic and mitochondrial assays included Seahorse ECAR/OCR, Lactate-Glo, 13C-glucose metabolic flux analysis, MitoSOX staining, RNA-seq/GSEA, FRET-based Laconic lactate sensing, LysoTracker/MitoTracker imaging, filipin III cholesterol staining, RFP-GFP-LC3 autophagy flux, cathepsin B activity, electron microscopy, and proteomics.
- Cholesterol-lowering treatments used methyl-β-cyclodextrin (MβCD) and simvastatin; statistical analysis used unpaired Student’s t-test or one-way ANOVA with Dunnett’s post hoc analysis.
Limitations
- The paper states that astrocytes were cultured with serum for expansion and serum-deprived for 4 days before experiments, but early serum exposure may still alter transcriptome, morphology, and function compared with cells never exposed to serum.
- The paper states that cholesterol mitigation rescued autophagy and mitochondrial abnormalities, but enhanced glycolytic activity was not fully restored even after long-term lysosomal cholesterol depletion; whether increased glycolysis precedes cholesterol accumulation or is cholesterol independent remains to be addressed.
- The paper notes that other adverse effects of disrupted lysosomal function by cholesterol could indirectly cause mitochondrial dysfunction, and that increased circular mitochondria on electron microscopy did not directly prove altered mitochondrial biogenesis/turnover or its causal relationship with metabolic abnormality; an evident limitation is the in vitro hiPSC-derived astrocyte system without in vivo validation.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
37 of 48 cited sources checked · 8 supported · 2 flagged · accuracy not yet measured
- Premisecitation§ Discussion
None of the previous studies attempted to provide causality among these pathological features and to restore the defects by ApoE4, especially in human astrocytes.
“However, none of these studies attempted to provide the causality among these pathological features and to restore the defects by ApoE4, especially in human astrocytes.”
Quote in the paperSubstantial claim3 of 3 sources checked- cites [4] Farmer, 2021, APOΕ4 lowers energy expenditure in females and impairs glucose oxidation by increasing flux through aerobic glycolysis, Mol. Neurodegener. source
The Materials and methods (Cell culture; page unavailable) describe mouse-derived astrocytes expressing human APOE alleles, not human astrocytes. The Results (Stable isotope resolved metabolomics; page unavailable) compare metabolic changes in E3 and E4 mice and astrocytes; the passages do not describe restoring those defects. This supports the characterization of this paper, but it cannot establish the broader claim about what none of the other studies attempted, or which pathological features they investigated for causality. (LLM, conf=0.76)
Experimental — accuracy not yet measured - cites [9] Qi, 2021, ApoE4 Impairs Neuron-Astrocyte Coupling of Fatty Acid Metabolism, Cell Rep. source
The Introduction identifies unanswered questions about ApoE variants and fatty-acid metabolism, but it does not say that none of the previous studies investigated causality or attempted to restore ApoE4-related defects. The Methods (page unavailable) describe astrocytes isolated from mice with humanized ApoE, not human astrocytes. Searches for causal relationships, restoration, and human astrocytes found no passage establishing the claim about previous studies. (LLM, conf=0.75)
Experimental — accuracy not yet measured - cites [23] Wu, 2018, Human ApoE Isoforms Differentially Modulate Brain Glucose and Ketone Body Metabolism: Implications for Alzheimer’s Disease Risk Reduction and Early Intervention, J. Neurosci. source
The Results section reports an intervention aimed at reversing ApoE4-associated deficits: PGC-1α overexpression in ApoE4-expressing N2a cells improved hexokinase activity and reversed defects in glycolytic reserve capacity. This contradicts the claim that none of the studies attempted to restore ApoE4-related defects. The experiment used N2a cells, not human astrocytes; our copy does not establish the broader claim about all previous studies. (LLM, conf=0.86)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
- Findingcitation§ Results
ApoE4 astrocytes display impaired Aβ clearance compared with ApoE3 astrocytes.
“ApoE4 astrocytes displayed reduced levels of ApoE and impaired Aβ clearance compared with ApoE3 astrocytes”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [5] Lin, 2018, APOE4 Causes Widespread Molecular and Cellular Alterations Associated with Alzheimer’s Disease Phenotypes in Human iPSC-Derived Brain Cell Types, Neuron source
- Findingcitation§ Results
ApoE4 astrocytes display reduced levels of ApoE compared with ApoE3 astrocytes.
“ApoE4 astrocytes displayed reduced levels of ApoE and impaired Aβ clearance compared with ApoE3 astrocytes”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [5] Lin, 2018, APOE4 Causes Widespread Molecular and Cellular Alterations Associated with Alzheimer’s Disease Phenotypes in Human iPSC-Derived Brain Cell Types, Neuron source
- Study design and conductcitation§ Discussion
Three ApoE3 and ApoE4 isogenic iPSC pairs were used to determine the effect of APOE4 genotype without inter-donor variability.
“Three ApoE3 and ApoE4 isogenic iPSCs pairs were used to determine the effect of APOE4 genotype without inter-donor variability.5”
Quote in the paperSubstantial claim3 of 3 sources checked- cites [5] Lin, 2018, APOE4 Causes Widespread Molecular and Cellular Alterations Associated with Alzheimer’s Disease Phenotypes in Human iPSC-Derived Brain Cell Types, Neuron source
The Results sections on generating APOE4 iPSCs and converting APOE4 to APOE3 describe isogenic comparisons, which allow APOE genotype to be examined within a donor background. They describe one pair derived from an unaffected subject and another from a sporadic AD patient, not three pairs. Page numbers are unavailable in our copy. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [12] Pantazis, 2022, A reference human induced pluripotent stem cell line for large-scale collaborative studies, Cell Stem Cell source
The Introduction says that genetic background can influence iPSC phenotypes and describes the value of isogenic comparisons. The Results identify APOE E4 in two cell lines, but neither passage reports using three APOE3/APOE4 isogenic pairs to assess genotype effects. Searches for the pairs and inter-donor variability found no passage establishing that study design. (LLM, conf=0.76)
Experimental — accuracy not yet measured - cites [40] Meyer, 2019, REST and Neural Gene Network Dysregulation in iPSC Models of Alzheimer’s Disease, Cell Rep. source
The Results section (‘APOE4 Induces Early Neuronal Differentiation and Dysregulation of REST’; page not provided) says the authors used isogenic iPSC lines differing only in APOE genotype to study its effects, which supports the rationale of avoiding inter-donor differences within a comparison. It describes editing lines from two donor backgrounds, not using three isogenic APOE3/APOE4 pairs. The three biological replicates reported in Methods are organoid samples, not three pairs. (LLM, conf=0.87)
Experimental — accuracy not yet measured
- Interpretationreasoning§ Discussion
Detrimental effects of impaired mitochondrial respiration in ApoE4 astrocytes could be magnified in later stages of life when the brain's metabolic dependency transitions from aerobic glycolysis to mitochondrial respiration.
“Thus, the detrimental effects of impaired mitochondrial respiration in ApoE4 astrocytes could be magnified in the later stages of life when the transition of metabolic dependency of the brain from aerobic glycolysis to mitochondrial respiration occurs.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [24] Goyal, 2017, Loss of Brain Aerobic Glycolysis in Normal Human Aging, Cell Metab. source
The Results and Discussion section (‘Whole brain AG decreases with age’; page unavailable) reports that aerobic glycolysis declines with age while whole-brain oxygen use remains relatively unchanged, supporting a shift in the relative contribution of these metabolic pathways. The paper studies cognitively normal human brains, not ApoE4 astrocytes, and does not test whether impaired mitochondrial respiration becomes more harmful later in life. It also does not establish a discrete transition to dependence on mitochondrial respiration. (LLM, conf=0.86)
Experimental — accuracy not yet measured
- Findingown data§ Results
ApoE4 astrocytes show significant accumulation of cholesterol compared with ApoE3 astrocytes.
“we found a significant accumulation of cholesterol in ApoE4 astrocytes compared with ApoE3 astrocytes”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [5] Lin, 2018, APOE4 Causes Widespread Molecular and Cellular Alterations Associated with Alzheimer’s Disease Phenotypes in Human iPSC-Derived Brain Cell Types, Neuron source
- cites [17] Lee, 2021, APOE4-carrying human astrocytes oversupply cholesterol to promote neuronal lipid raft expansion and Aβ generation, Stem Cell Rep. source
The Results section reports prior findings of intracellular cholesterol accumulation in ApoE4 astrocytes compared with isogenic ApoE3 astrocytes. It does not state that this difference was statistically significant; this paper’s own measurements concern cholesterol secreted into astrocyte-conditioned media, not accumulation within the astrocytes. No page number is available in our copy. (LLM, conf=0.82)
Experimental — accuracy not yet measured
- Premisecitation§ Discussion
Human studies have shown that impaired cognitive performance in ApoE4 carriers is prominent after middle age.
“Indeed, human studies have shown that impaired cognitive performance in ApoE4 carriers is prominent after middle age.25”
Quote in the paperNot a substantial claim2 of 2 sources checked - Findingown data§ Results
A 4-day treatment with 100 μM methyl-β-cyclodextrin (MβCD) mitigates lysosomal cholesterol accumulation in ApoE4 hiPSC-derived astrocytes.
“We were able to mitigate lysosomal cholesterol accumulation in ApoE4 hiPSC-derived astrocytes with a 4-day treatment of 100 μM methyl-β-cyclodextrin (MβCD)”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [18] Li, 2017, Analytical Characterization of Methyl-β-Cyclodextrin for Pharmacological Activity to Reduce Lysosomal Cholesterol Accumulation in Niemann-Pick Disease Type C1 Cells, Assay Drug Dev. Technol. source
The Results section (Fig. 4; page not provided) reports that four days of MβCD treatment reduced cholesterol accumulation in NPC1 patient fibroblasts. It does not report an experiment in ApoE4 hiPSC-derived astrocytes or establish the claimed effect specifically at 100 μM. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [19] Swaroop, 2012, Evaluation of Cholesterol Reduction Activity of Methyl-β-cyclodextrin Using Differentiated Human Neurons and Astrocytes, J. Biomol. Screen source
The Results report that MβCD reduced cellular cholesterol in human astrocytes, but the Methods identify those cells as derived from normal human brain tissue, not ApoE4 hiPSCs. The Methods describe cholesterol measurements after 1 or 3 days of treatment, not a 4-day, 100 μM regimen; the paper does not establish a reduction specifically in lysosomal cholesterol in ApoE4 astrocytes. (LLM, conf=0.90)
Experimental — accuracy not yet measured
- Findingown data§ Results
ATP-linked respiration is significantly reduced in ApoE4 astrocytes.
“A significant reduction in ATP-linked respiration indicated that basal respiration was not efficiently coupled with ATP synthesis in ApoE4 astrocytes.”
Quote in the paperSubstantial claim - Findingown data§ Results
Increased ROS levels induced by ApoE4 were also detected in another isogenic pair derived from a healthy individual with the APOE3 genotype.
“Increased ROS levels induced by ApoE4 were also detected in another isogenic pair derived from a healthy individual with the APOE3 genotype”
Quote in the paperNot a substantial claim - Findingown data§ Results
Reserve capacity is significantly reduced in ApoE4 astrocytes.
“The reserve capacity was also significantly reduced in these cells”
Quote in the paperSubstantial claim - Findingown data§ 6 Send email to gotra827@kiom.re.kr ∙ In-Kyu Lee
Acute treatment with cholesterol-depleting agents restores autophagic activity, mitochondrial dynamics, and associated proteomes in ApoE4 astrocytes.
“Acute treatment with cholesterol-depleting agents restores autophagic activity, mitochondrial dynamics, and associated proteomes”
Quote in the paperSubstantial claim - Findingown data§ Results
ApoE4 does not alter fractional enrichment of TCA cycle intermediates.
“Although ApoE4 did not show altered fractional enrichment of TCA cycle intermediates”
Quote in the paperNot a substantial claim - Findingown data§ 6 Send email to gotra827@kiom.re.kr ∙ In-Kyu Lee
Extended treatment with cholesterol-depleting agents rescues mitochondrial respiration in ApoE4 astrocytes.
“extended treatment rescues mitochondrial respiration in ApoE4 astrocytes”
Quote in the paperSubstantial claim - Findingown data§ Results
Many genes associated with glycolysis and OXPHOS are regulated by ApoE4.
“We found that many genes associated with glycolysis and OXPHOS were regulated by ApoE4”
Quote in the paperSubstantial claim - Findingown data§ Results
Maximal respiration is decreased in ApoE4 astrocytes.
“Maximal respiration by FCCP-induced inner mitochondrial membrane depolarization was also decreased in ApoE4 astrocytes, suggesting inefficient energy generation.”
Quote in the paperSubstantial claim - Findingown data§ Results
ApoE4 astrocytes have higher mitochondrial ROS levels than isogenic ApoE3 cells.
“a higher intensity of MitoSOX signals, indicating an increased level of ROS in mitochondria (Figures 2F–2H), was observed in ApoE4 astrocytes compared with that in isogenic ApoE3 cells.”
Quote in the paperSubstantial claim - Findingown data§ Results
Glutamate and aspartate synthesis from the TCA cycle is affected in ApoE4 astrocytes.
“glutamate and aspartate synthesis from the TCA cycle was affected”
Quote in the paperNot a substantial claim - Findingown data§ Results
There is no change in the fractions of pyruvate and glucose-3-phosphate between ApoE3 and ApoE4 astrocytes.
“We did not observe any change in the fractions of pyruvate and glycose-3-phosphate between ApoE3 and ApoE4 astrocytes”
Quote in the paperNot a substantial claim - Findingown data§ Results
Basal respiration rate is significantly reduced in ApoE4 astrocytes compared with ApoE3 astrocytes.
“The oxygen consumption rate assay showed a significantly reduced basal respiration rate in ApoE4 astrocytes compared with that in ApoE3 astrocytes”
Quote in the paperSubstantial claim - Findingown data§ Results
Lactate release is increased from ApoE4 astrocytes compared with their isogenic ApoE3 cells.
“the results confirmed an increase in lactate release from ApoE4 astrocytes compared with their isogenic cells”
Quote in the paperSubstantial claim - Findingown data§ Results
ApoE4 astrocytes show increased glycolytic activity compared with ApoE3 astrocytes.
“we observed an increase in ECAR upon glucose treatment in ApoE4 astrocytes compared with that in ApoE3 astrocytes, suggesting enhanced glycolysis”
- Also stated in: § 6 Send email to gotra827@kiom.re.kr ∙ In-Kyu Lee · plain
“Human ApoE4 astrocytes display increased glycolytic activity and reduced OXPHOS”
Quote in the paperSubstantial claim - Also stated in: § 6 Send email to gotra827@kiom.re.kr ∙ In-Kyu Lee · plain
- Findingown data§ Results
ApoE4 astrocytes have increased lysosomal area compared with ApoE3 cells.
“We repeatedly observed an increased lysosomal area, although the mitochondrial area was indistinguishable in ApoE4 astrocytes compared with ApoE3 cells”
Quote in the paperSubstantial claim - Findingown data§ Abstract
Alteration in glucose metabolism-associated pathways was not restored by short-term MβCD treatment.
“But consistent with the Seahourse analysis (Figures S6J and S6K), an alteration in glucose metabolism-associated pathways was not restored by short-term MβCD treatment (Figure S6L).”
Quote in the paperNot a substantial claim - Findingown data§ Results
There is no difference in the effect of APOE genotype on total levels of lactate synthesis.
“Although we did not find the difference in the effect of APOE genotype on total levels of lactate synthesis”
Quote in the paperNot a substantial claim - Findingown data§ Results
Four days of MβCD treatment was insufficient to restore OXPHOS in ApoE4 astrocytes.
“We found that 4 days of MβCD treatment was insufficient to restore both glycolytic activity and OXPHOS in ApoE4 astrocytes (Figures S6J and S6K).”
Quote in the paperSubstantial claim - Findingown data§ Results
The area of individual mitochondria was significantly increased in ApoE4 astrocytes.
“to determine that the area of individual mitochondria was significantly increased in ApoE4 astrocytes (Figure 5F).”
Quote in the paperSubstantial claim - Findingown data§ Discussion
ApoE4 astrocytes display lysosomal dysfunction.
“ApoE4 astrocytes display lysosomal dysfunction and impaired autophagic activity, leading to the accumulation of damaged and high-ROS mitochondria.”
Quote in the paperSubstantial claim - Findingown data§ Results
Lysosomal activity is restored after lysosomal cholesterol depletion, as indicated by mitigated LysoTracker intensity.
“We further observed restoration of lysosomal activity, as indicated by the mitigated intensity of LysoTracker after lysosomal cholesterol depletion”
Quote in the paperSubstantial claim - Findingown data§ Discussion
ApoE4 reduces mitochondrial respiration in human astrocytes.
“In this study, we found that ApoE4, which greatly increases the risk of AD and lowers the age of onset, leads to abnormal glucose metabolism toward enhanced glycolysis and reduces mitochondrial respiration in human astrocytes.”
Quote in the paperSubstantial claim- Rests on an assumption: ApoE4 greatly increases the risk of AD and lowers the age of onset.
- Findingown data§ Results
In KOLF2.1J isogenic ApoE4 iPSC-derived astrocytes, ApoE4 increases glycolytic activity.
“Consistently, we observed an ApoE4-dependent increase in glycolytic activity and reduced OXPHOS along with enhanced levels of MitoSOX in this isogenic pair”
Quote in the paperSubstantial claim - Findingown data§ Results
In KOLF2.1J isogenic ApoE4 iPSC-derived astrocytes, ApoE4 enhances MitoSOX levels.
“Consistently, we observed an ApoE4-dependent increase in glycolytic activity and reduced OXPHOS along with enhanced levels of MitoSOX in this isogenic pair”
Quote in the paperSubstantial claim - Findingown data§ Results
Four days of MβCD treatment was insufficient to restore glycolytic activity in ApoE4 astrocytes.
“We found that 4 days of MβCD treatment was insufficient to restore both glycolytic activity and OXPHOS in ApoE4 astrocytes (Figures S6J and S6K).”
Quote in the paperSubstantial claim - Findingown data§ Results
Mitochondria in ApoE4 astrocytes were less complex than those in ApoE3 astrocytes.
“Furthermore, mitochondria in ApoE4 astrocytes were more circular and less complex, although there was no difference in perimeter compared with those in ApoE3 astrocytes (Figures 5G–5J).”
Quote in the paperNot a substantial claim - Findingown data§ Discussion
Mitigating intracellular accumulation of cholesterol, especially in lysosomes, restores mitochondrial homeostasis in ApoE4 astrocytes.
“Here, by mitigating the intracellular accumulation of cholesterol, especially in lysosomes, we restore autophagic activity and mitochondrial homeostasis in ApoE4 astrocytes.”
Quote in the paperSubstantial claim - Findingown data§ Results
ApoE4 astrocytes display an approximately 50% increase in cathepsin B activity compared with ApoE3 astrocytes.
“ApoE4 astrocytes displayed an approximately 50% increase in cathepsin B activity compared with ApoE3 astrocytes”
Quote in the paperSubstantial claim - Findingown data§ Abstract
Two hundred fifty-four proteins were downregulated in ApoE4 astrocytes compared with ApoE3 astrocytes.
“We found that 254 proteins were downregulated and 238 proteins were upregulated in ApoE4 astrocytes compared with those in ApoE3 astrocytes.”
Quote in the paperNot a substantial claim - Findingown data§ Discussion
Mitigating intracellular accumulation of cholesterol, especially in lysosomes, restores autophagic activity in ApoE4 astrocytes.
“Here, by mitigating the intracellular accumulation of cholesterol, especially in lysosomes, we restore autophagic activity and mitochondrial homeostasis in ApoE4 astrocytes.”
Quote in the paperSubstantial claim - Findingown data§ Results
Aβ induces an increase in glycolytic activity in hiPSC-derived astrocytes.
“We found that Aβ also induces an increase in glycolytic activity in hiPSC-derived astrocytes”
Quote in the paperNot a substantial claim - Findingown data§ Results
Mitochondrial area is indistinguishable between ApoE4 and ApoE3 astrocytes.
“We repeatedly observed an increased lysosomal area, although the mitochondrial area was indistinguishable in ApoE4 astrocytes compared with ApoE3 cells”
Quote in the paperNot a substantial claim - Findingown data§ Discussion
ApoE4 astrocytes show slow decay of glutamate-induced lactate synthesis.
“As we observed a slow decay of glutamate-induced lactate synthesis in ApoE4 astrocytes, further studies are required to determine whether activity-induced lactate supply to neurons and associated cognitive behavior are affected by ApoE4 astrocytes in vivo.”
Quote in the paperSubstantial claim - Findingown data§ Results
There is a statistically significant interaction effect between time and genotypes (p < 0.05) for lactate synthesis upon glutamate stimulation, due to a sharp transient increase followed by slow decay in ApoE4 astrocytes.
“a statistically significant interaction effect between time and genotypes (two-way ANOVA, time × genotype interaction: p < 0.05) was observed due to a relatively sharp transient increase followed by the slow decay of lactate synthesis upon glutamate stimulation in ApoE4 astrocytes”
Quote in the paperNot a substantial claim - Findingown data§ Discussion
ApoE4 astrocytes display impaired autophagic activity.
“ApoE4 astrocytes display lysosomal dysfunction and impaired autophagic activity, leading to the accumulation of damaged and high-ROS mitochondria.”
Quote in the paperSubstantial claim - Findingown data§ Discussion
ApoE4 leads to abnormal glucose metabolism toward enhanced glycolysis in human astrocytes.
“In this study, we found that ApoE4, which greatly increases the risk of AD and lowers the age of onset, leads to abnormal glucose metabolism toward enhanced glycolysis and reduces mitochondrial respiration in human astrocytes.”
Quote in the paperSubstantial claim- Rests on an assumption: ApoE4 greatly increases the risk of AD and lowers the age of onset.
- Findingown data§ Abstract
Extended MβCD treatment failed to normalize glycolytic activity in ApoE4 astrocytes.
“However, the extended treatment failed to normalize glycolytic activity in ApoE4 astrocytes (Figures 5K–5O)”
Quote in the paperSubstantial claim - Findingown data§ Results
Lysosome size is increased in ApoE4 astrocytes.
“We observed an increase in the size of lysosomes in ApoE4 astrocytes”
Quote in the paperSubstantial claim - Findingown data§ Abstract
Thirty-four out of 238 upregulated proteins were restored by MβCD treatment (p = 6.01−36).
“Moreover, a statistically significant number of proteins in the list were restored by MβCD treatment (16 out of 254 downregulated, p = 1.3−14, 34 out of 238 upregulated, p = 6.01−36) (Figure 6A; Table S1).”
Quote in the paperSubstantial claim - Findingown data§ Results
Mitochondria in ApoE4 astrocytes were more circular than those in ApoE3 astrocytes.
“Furthermore, mitochondria in ApoE4 astrocytes were more circular and less complex, although there was no difference in perimeter compared with those in ApoE3 astrocytes (Figures 5G–5J).”
Quote in the paperNot a substantial claim - Findingown data§ Abstract
Sixteen out of 254 downregulated proteins were restored by MβCD treatment (p = 1.3−14).
“Moreover, a statistically significant number of proteins in the list were restored by MβCD treatment (16 out of 254 downregulated, p = 1.3−14, 34 out of 238 upregulated, p = 6.01−36) (Figure 6A; Table S1).”
Quote in the paperSubstantial claim - Findingown data§ Results
p62 and LC3 levels are significantly increased in ApoE4 astrocytes compared with ApoE3 astrocytes.
“We observed that both p62 and LC3 levels were significantly increased in ApoE4 astrocytes compared with those in ApoE3 astrocytes”
Quote in the paperSubstantial claim - Findingown data§ Abstract
Two hundred thirty-eight proteins were upregulated in ApoE4 astrocytes compared with ApoE3 astrocytes.
“We found that 254 proteins were downregulated and 238 proteins were upregulated in ApoE4 astrocytes compared with those in ApoE3 astrocytes.”
Quote in the paperNot a substantial claim - Findingown data§ Abstract
Analysis of differentially expressed proteins confirmed the rescue of a subset of proteins related to mitophagy and metabolic pathways.
“The analysis of differentially expressed proteins further confirmed the rescue of a subset of proteins related to “mitophagy” and “metabolic pathways” (Figure 6D).”
Quote in the paperNot a substantial claim - Findingown data§ Results
Simvastatin treatment normalizes ApoE4-dependent increases in lysosomal cholesterol accumulation and LysoTracker-positive areas in astrocytes.
“Simvastatin treatment also normalized ApoE4-dependent increases in lysosomal cholesterol accumulation and LysoTracker-positive areas in astrocytes”
Quote in the paperSubstantial claim - Findingown data§ Results
MβCD treatment completely restored all mitochondrial structural abnormalities observed in ApoE4 astrocytes.
“All mitochondrial structural abnormalities observed in ApoE4 astrocytes were completely restored by MβCD treatment (Figures 5E–5J).”
Quote in the paperSubstantial claim - Findingown data§ Results
ApoE4 increases the intensity of LysoTracker in astrocytes.
“We also observed that ApoE4 increased the intensity of LysoTracker, which is positively associated with lysosomal activity”
Quote in the paperSubstantial claim - Findingown data§ Results
In KOLF2.1J isogenic ApoE4 iPSC-derived astrocytes, ApoE4 reduces OXPHOS.
“Consistently, we observed an ApoE4-dependent increase in glycolytic activity and reduced OXPHOS along with enhanced levels of MitoSOX in this isogenic pair”
Quote in the paperSubstantial claim - Findingown data§ Abstract
Pathway analysis predicted abnormalities in various signaling pathways in ApoE4 astrocytes.
“Pathway analysis predicted abnormalities in various signaling pathways in ApoE4 astrocytes.”
Quote in the paperNot a substantial claim - Findingown data§ Results
The area of individual mitochondria is significantly increased in ApoE4 astrocytes.
“We were able to determine that the area of individual mitochondria was significantly increased in ApoE4 astrocytes”
Quote in the paperSubstantial claim - Findingown data§ Abstract
Many pathways, including those related to autophagy and protein degradation, were normalized by MβCD treatment.
“Many of these pathways, including those related to autophagy and protein degradation, were normalized by MβCD treatment (Figure 6B).”
Quote in the paperSubstantial claim - Findingown data§ Results
There was no difference in mitochondrial perimeter between ApoE4 and ApoE3 astrocytes.
“Furthermore, mitochondria in ApoE4 astrocytes were more circular and less complex, although there was no difference in perimeter compared with those in ApoE3 astrocytes (Figures 5G–5J).”
Quote in the paperNot a substantial claim - Findingown data§ Abstract
Fourteen days of MβCD treatment restored mitochondrial respiration in ApoE4 astrocytes.
“Indeed, we observed that 14 days of MβCD treatment restored mitochondrial respiration.”
Quote in the paperSubstantial claim - Findingown data§ Results
Cholesterol accumulation in ApoE4 astrocytes is predominantly observed in lysosomes.
“which was predominantly observed in lysosomes”
Quote in the paperSubstantial claim - Interpretationown data§ 6 Send email to gotra827@kiom.re.kr ∙ In-Kyu Lee
The study provides a direct link between ApoE4-induced lysosomal cholesterol accumulation and abnormal oxidative phosphorylation.
“our study provides a direct link between ApoE4-induced lysosomal cholesterol accumulation and abnormal oxidative phosphorylation.”
Quote in the paperSubstantial claim - Interpretationown data§ Results
ApoE4 alters glucose metabolism toward enhanced aerobic glycolysis in human astrocytes.
“Taken together, these data suggest that ApoE4 alters glucose metabolism toward enhanced aerobic glycolysis.”
Quote in the paperSubstantial claim - Study design and conductown data§ Results
The identity of human iPSC-derived astrocytes was confirmed by immunostaining for astrocyte-specific proteins AQP4, ALDH1L1, S100β, and GFAP.
“The identity of human iPSC (hiPSC)-derived astrocytes was confirmed by immunostaining based on the expression profiles of astrocyte-specific proteins (AQP4, ALDH1L1, S100β, and GFAP)”
Quote in the paperSubstantial claim - Interpretationown data§ 6 Send email to gotra827@kiom.re.kr ∙ In-Kyu Lee
ApoE4-induced cholesterol accumulation impairs lysosome-dependent removal of damaged mitochondria in human astrocytes.
“Ultrastructural and autophagy flux analyses show that ApoE4-induced cholesterol accumulation impairs lysosome-dependent removal of damaged mitochondria.”
Quote in the paperSubstantial claim - Study design and conductown data§ Results
The human iPSC-derived astrocytes were successfully generated as ApoE3 and ApoE4 astrocytes.
“These data show the successful generation of human ApoE3 and ApoE4 astrocytes.”
Quote in the paperSubstantial claim - Interpretationown data§ Results
ApoE4 impairs mitochondrial oxidative phosphorylation (OXPHOS) in human astrocytes.
“Taken together, these data indicate that ApoE4 impairs mitochondrial oxidative phosphorylation (OXPHOS) in human astrocytes.”
Quote in the paperSubstantial claim - Premisecitation§ Discussion
Increased acidification triggers Aβ aggregation.
“It is also important to note that increased acidification was shown to trigger Aβ aggregation,36”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [36] Su, 2001, Acidic pH promotes the formation of toxic fibrils from β-amyloid peptide, Brain Res. source
- Interpretationown data§ Results
Transcriptional regulation contributes to glucose metabolism changes in ApoE4 astrocytes.
“These data suggest the contribution of transcriptional regulation in glucose metabolism in ApoE4 astrocytes.”
Quote in the paperSubstantial claim - Interpretationown data§ Results
ApoE4 astrocytes show a potential alteration in glycolysis in response to glutamate.
“These data suggest a potential alteration in glycolysis of ApoE4 astrocytes in response to glutamate, the major excitatory neurotransmitter.”
Quote in the paperNot a substantial claim - Study design and conductown data§ Discussion
Electron microscopy did not provide direct evidence of ApoE4-induced perturbation of mitochondrial biogenesis or turnover and its causal relationship with metabolic abnormality.
“Finally, while increased circular forms of mitochondria in ApoE4 astrocytes observed by electron microscopy suggested accumulation of dysfunctional mitochondria, it did not provide direct evidence of ApoE4-induced perturbation of mitochondrial biogenesis or turnover and its causal relationship with metabolic abnormality.”
Quote in the paperNot a substantial claim - Interpretationown data§ Discussion
Our data identify a possible contribution of ApoE4 to dysfunctional brain metabolism in AD pathogenesis.
“our data identify a possible contribution of ApoE4 to this process.”
Quote in the paperSubstantial claim - Interpretationown data§ Results
ApoE4 astrocytes show abnormal accumulation of autophagosomes due to impaired autolysosomal degradation.
“suggesting abnormal accumulation of autophagosomes (increased LC3 levels) by impaired autolysosomal degradation (increased p62 levels) in ApoE4 astrocytes”
Quote in the paperSubstantial claim - Interpretationown data§ Results
ApoE4 causes dysregulation of lysosomes in hiPSC-derived astrocytes.
“These data indicated ApoE4-dependent dysregulation of lysosomes in hiPSC-derived astrocytes.”
Quote in the paperSubstantial claim - Interpretationreasoning§ Discussion
Lysosomal dysfunction and impaired autophagic activity lead to the accumulation of damaged and high-ROS mitochondria in ApoE4 astrocytes.
“ApoE4 astrocytes display lysosomal dysfunction and impaired autophagic activity, leading to the accumulation of damaged and high-ROS mitochondria.”
Quote in the paperSubstantial claim - Interpretationown data§ Discussion
ApoE4 may impair the physiological functions of astrocytes, especially those associated with glycolytic activity.
“By measuring lactate synthesis in real time using the FRET-based lactate sensor Laconic, we provide evidence that ApoE4 may impair the physiological functions of astrocytes, especially those associated with glycolytic activity.”
Quote in the paperSubstantial claim - Interpretationown data§ Discussion
Cholesterol dysregulation and autophagic defects cause the accumulation of dysfunctional mitochondria in ApoE4 astrocytes.
“Thus, we provide strong evidence associating cholesterol dysregulation and autophagic defects causing the accumulation of dysfunctional mitochondria in astrocytes by ApoE4.”
Quote in the paperSubstantial claim - Interpretationreasoning§ Discussion
The transition from aerobic glycolysis to mitochondrial respiration can trigger the development of pathology by ApoE4 in astrocytes due to impaired mitochondrial function, limited metabolic supply, and accumulation of oxidative stress.
“This transition can trigger the development of pathology by ApoE4 in astrocytes due to impaired mitochondrial function, limited metabolic supply, and accumulation of oxidative stress.”
Quote in the paperSubstantial claim - Interpretationown data§ Abstract
ApoE4-induced enhancement of glycolytic activity might be cholesterol independent.
“suggesting that ApoE4-induced enhancement of glycolytic activity might be cholesterol independent.”
Quote in the paperSubstantial claim
- Classified as probably not a substantial claim. 31
- May combine two claims. 20
Classified as probably not a substantial claim.
Premisecitation§ ResultsCholesterol accumulation in lysosomes impairs lysosomal functions, including autophagy-mediated mitochondrial degradation, in various pathological conditions, including Niemann-Pick disease type C.
“Cholesterol accumulation in lysosomes has been shown to impair lysosomal functions, including autophagy-mediated mitochondrial degradation, in various pathological conditions, including Niemann-Pick disease type C.15”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [15] Maetzel, 2014, Genetic and Chemical Correction of Cholesterol Accumulation and Impaired Autophagy in Hepatic and Neural Cells Derived from Niemann-Pick Type C Patient-Specific iPS Cells, Stem Cell Rep. source
The Results section on the NPC1 mutation reports both cholesterol accumulation and impaired autophagic flux, but says that depleting cholesterol did not rescue the autophagy defect. It instead links the defect to loss of NPC1 function, contrary to the claimed causal role of cholesterol accumulation in NPC. The paper does not specifically report impaired autophagy-mediated mitochondrial degradation. (LLM, conf=0.85)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured - cites [16] Davis, 2021, NPC1-mTORC1 Signaling Couples Cholesterol Sensing to Organelle Homeostasis and Is a Targetable Pathway in Niemann-Pick Type C, Dev. Cell source
The Introduction links lysosomal cholesterol accumulation in NPC1-deficient cells to lysosomal dysfunction, and the Results report impaired steps in mitophagy, the autophagic clearance of mitochondria (page numbers unavailable). The paper supports the claim for Niemann-Pick type C, but does not establish that cholesterol accumulation causes these effects across the various other pathological conditions claimed. (LLM, conf=0.86)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisecitation§ IntroductionAbnormal glucose metabolism is one of the major pathological features of Alzheimer's disease and is observed in the early phase of disease progression.
“Abnormal glucose metabolism is one of the major pathological features of Alzheimer’s disease (AD) and is observed in the early phase of disease progression.1”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [1] Gordon, 2018, Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer disease: a longitudinal study, Lancet Neurol. source
Classified as probably not a substantial claim.
Premisecitation§ IntroductionRecent studies on human induced pluripotent stem cells with the APOE4 variant showed altered transcriptomic and metabolomic profiles toward the accumulation of cholesterol in glia, such as astrocytes and oligodendrocytes.
“Recent studies on human induced pluripotent stem cells (iPSCs) with the APOE4 variant showed altered transcriptomic and metabolomic profiles toward the accumulation of cholesterol in glia, such as astrocytes and oligodendrocytes.5”
Quote in the paperSubstantial claim3 of 3 sources checked- cites [5] Lin, 2018, APOE4 Causes Widespread Molecular and Cellular Alterations Associated with Alzheimer’s Disease Phenotypes in Human iPSC-Derived Brain Cell Types, Neuron source
The Results section (“APOE4 astrocytes exhibit compromised Aβ uptake”; page unavailable) reports altered lipid-metabolism gene expression and increased cholesterol in APOE4 iPSC-derived astrocytes. It does not report cholesterol accumulation in oligodendrocytes or a metabolomic profile; cholesterol was measured with targeted assays. (LLM, conf=0.90)
Experimental — accuracy not yet measured - cites [6] Victor, 2022, Lipid accumulation induced by APOE4 impairs microglial surveillance of neuronal-network activity, Cell Stem Cell source
The Results section, “Imbalance in the net flux of lipids by APOE4 iMGLs” (page unavailable), reports transcriptional profiling and increased extracellular cholesterol in APOE4 iPSC-derived microglia. The Discussion section, “Cholesterol homeostasis” (page unavailable), reports prior findings of extracellular cholesterol accumulation in APOE4 iPSC-derived astrocytes. The cited paper does not report this finding for oligodendrocytes or describe the claimed metabolomic profiling. (LLM, conf=0.87)
Experimental — accuracy not yet measured - cites [7] TCW, 2022, Cholesterol and matrisome pathways dysregulated in astrocytes and microglia, Cell source
The Results sections on altered lipid metabolism and impaired cholesterol trafficking report APOE4-associated transcriptomic changes and increased intracellular cholesterol in hiPSC-derived astrocytes, supported by cholesterol measurements. The paper studies astrocytes and microglia, not oligodendrocytes, and the cited passages do not establish altered metabolomic profiles across glial cell types. Page numbers are unavailable in our copy. (LLM, conf=0.88)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ IntroductionAltered brain metabolism, especially increased aerobic glycolysis and impaired oxygen consumption in the brains of ApoE4 carriers, is suggested by studies from human plasma and humanized mouse models.
“Altered brain metabolism, especially increased aerobic glycolysis and impaired oxygen consumption in the brains of ApoE4 carriers, is suggested in studies from human plasma and humanized mouse models.2”
Quote in the paperNot a substantial claim1 of 3 sources checked- cites [2] Ercoli, 2006, Perceived Loss of Memory Ability and Cerebral Metabolic Decline in Persons With the Apolipoprotein E-IV Genetic Risk for Alzheimer Disease, Arch Gen Psychiat source
- cites [3] Cho, 2021, Impact of Genetic Risk Factors for Alzheimer’s Disease on Brain Glucose Metabolism, Mol. Neurobiol. source
- cites [4] Farmer, 2021, APOΕ4 lowers energy expenditure in females and impairs glucose oxidation by increasing flux through aerobic glycolysis, Mol. Neurodegener. source
The Results and Discussion report increased aerobic glycolysis in brains of mice expressing human APOE4, alongside decreased oxygen consumption in E4 astrocytes. In human participants, the paper measured plasma metabolites and whole-body oxygen consumption, not oxygen consumption in carriers’ brains. The claim therefore extends the oxygen-consumption finding beyond the tissue measured. (LLM, conf=0.84)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ DiscussionInhibiting lactate transfer from astrocytes to neurons abolishes hippocampal and cortical synaptic plasticity under stress conditions in mice.
“Another study reported that inhibiting lactate transfer from astrocytes to neurons abolished hippocampal and cortical synaptic plasticity under stress conditions in mice.38”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [38] Murphy-Royal, 2020, Stress gates an astrocytic energy reservoir to impair synaptic plasticity, Nat. Commun. source
In Results, “Astrocyte to neuron lactate shuttle is impaired by stress” (page unavailable), inhibiting lactate transport abolished lactate-mediated rescue of neocortical LTP in stressed mice. The hippocampal experiment instead found that stress reduced—but did not abolish—LTP and that supplying lactate rescued it; it did not show that inhibiting lactate transfer abolished hippocampal plasticity. (LLM, conf=0.90)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ DiscussionThe astrocyte-neuron lactate shuttle regulates neuronal activity.
“Increased levels of lactate have also been shown to be correlated with neuronal network activity, as the astrocyte-neuron lactate shuttle is known to regulate neuronal activity.31”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [31] Suzuki, 2011, Astrocyte-neuron lactate transport is required for long-term memory formation, Cell source
The Results section reports that training increased hippocampal lactate and that blocking glycogen metabolism disrupted maintenance of hippocampal long-term potentiation, an effect rescued by lactate. This supports a role for astrocyte–neuron lactate transport in activity-related synaptic plasticity, but the paper does not directly establish a correlation between lactate levels and neuronal network activity or show regulation of baseline neuronal activity. Page numbers were unavailable in our copy. (LLM, conf=0.82)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisecitation§ DiscussionPathological changes in AD brains precede the onset of clinical symptoms, and one of the first alterations, along with Aβ accumulation, is dysfunctional glucose metabolism.
“Pathological changes in AD brains precede the onset of clinical symptoms, and one of the first alterations, along with Aβ accumulation, is dysfunctional glucose metabolism.1”
Quote in the paperNot a substantial claim2 of 3 sources checked- cites [1] Gordon, 2018, Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer disease: a longitudinal study, Lancet Neurol. source
The Discussion reports that Aβ deposition was the first neuroimaging biomarker to differ between groups, followed by metabolic decline, both well before expected dementia onset. The study examined families with autosomal dominant AD; it does not establish that this timing applies to AD brains generally. (LLM, conf=0.84)
Experimental — accuracy not yet measured - cites [27] Weise, 2018, Left lateralized cerebral glucose metabolism declines in amyloid-β positive persons with mild cognitive impairment, Neuroimage. Clin. source
- cites [28] Croteau, 2018, A cross-sectional comparison of brain glucose and ketone metabolism in cognitively healthy older adults, mild cognitive impairment and early Alzheimer’s disease, Exp. Gerontol. source
Classified as probably not a substantial claim.
Premisecitation§ ResultsThe half-life of mitochondria is a couple of weeks in several cell types.
“The half-life of mitochondria is known to be a couple of weeks in several cell types,20”
Quote in the paperSubstantial claim1 of 3 sources checked- cites [20] Krishna, 2021, Identification of long-lived proteins in the mitochondria reveals increased stability of the electron transport chain, Dev. Cell source
The Results section reports mitochondrial-protein half-lives in two cell types: 7 days in neurons and 5.5 days in myotubes. That supports the broader point that mitochondrial turnover varies by cell type, but it does not establish a roughly two-week half-life for mitochondria themselves; the paper says the lifespan of individual mitochondria is unknown. (LLM, conf=0.84)
Experimental — accuracy not yet measured - cites [21] Facundo, 2017, Mitochondria and Cardiac Hypertrophy, Adv. Exp. Med. Biol. source
- cites [22] Menzies, 1971, The Turnover of Mitochondria in a Variety of Tissues of Young Adult and Aged Rats, J. Biol. Chem. source
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ DiscussionIncreased levels of lactate are correlated with neuronal network activity.
“Increased levels of lactate have also been shown to be correlated with neuronal network activity, as the astrocyte-neuron lactate shuttle is known to regulate neuronal activity.31”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [31] Suzuki, 2011, Astrocyte-neuron lactate transport is required for long-term memory formation, Cell source
The Results section, “Learning-induced astrocytic release of lactate is required for memory formation” (page unavailable), reports that hippocampal lactate increased after training. The Introduction and Discussion link lactate transport to neuronal activity, but the paper does not report a direct correlation between lactate levels and measured neuronal network activity. (LLM, conf=0.82)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisecitation§ DiscussionYoung ApoE4 carriers showed increased brain activity in default network regions, as well as in the hippocampus and the temporal lobe, possibly due to increased aerobic glycolysis.
“Young ApoE4 carriers showed increased brain activity in default network regions, as well as in the hippocampus and the temporal lobe, possibly due to increased aerobic glycolysis.34”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [34] Vlassenko, 2010, Spatial correlation between brain aerobic glycolysis and amyloid-β (Aβ ) deposition, Proc. Natl. Acad. Sci. USA source
- cites [35] Filippini, 2009, Distinct patterns of brain activity in young carriers of the APOE-epsilon4 allele, Proc. Natl. Acad. Sci. USA source
The Results report greater default-mode-network coactivation in medial temporal, medial-prefrontal, and retrosplenial regions, as well as greater hippocampal activation during memory encoding in young APOE ε4 carriers. They do not establish a separate increase across the temporal lobe or suggest increased aerobic glycolysis as an explanation; the Discussion considers other possible mechanisms. (LLM, conf=0.88)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ DiscussionIncreased cholesterol levels can be caused by enhanced glycolysis and the subsequent synthesis of acetyl-CoA, a source of cholesterol synthesis.
“Increased cholesterol levels can be caused by enhanced glycolysis and the subsequent synthesis of acetyl-CoA, a source of cholesterol synthesis,39”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [39] Shi, 2022, Intracellular Cholesterol Synthesis and Transport, Front. Cell Dev. Biol. source
The Introduction’s “Cholesterol Synthesis” section identifies acetyl-CoA as a starting material for cholesterol synthesis. It does not say that enhanced glycolysis increases acetyl-CoA production or causes cholesterol levels to rise; searches for glycolysis and that proposed link found no supporting passage. Page numbers were not available in our copy. (LLM, conf=0.87)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ DiscussionLactate levels in the interstitial fluid were higher in patients than in unaffected individuals.
“Lactate levels in the interstitial fluid were higher in patients than those in unaffected individuals.29”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [29] Carroll, 2019, The Interaction Between Sleep and Metabolism in Alzheimer’s Disease: Cause or Consequence of Disease?, Front. Aging Neurosci. source
The “Glucose Metabolism and Neuronal Activity in AD” section (page unavailable) reports increased interstitial-fluid lactate after induced hyperglycemia in rodents, with a greater effect in mice with substantial amyloid pathology. It does not report higher interstitial-fluid lactate in patients than in unaffected people; the cited comparison changes both the population and condition. (LLM, conf=0.82)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisecitation§ DiscussionPrevious studies reported altered glucose metabolism, dysregulated lipid homeostasis, and lysosomal/autophagosomal impairments by ApoE4 in various cell types, including neurons and astrocytes.
“altered glucose metabolism, dysregulated lipid homeostasis, and lysosomal/autophagosomal impairments by ApoE4 in various cell types, including neurons and astrocytes.”
Quote in the paperNot a substantial claim3 of 3 sources checked- cites [4] Farmer, 2021, APOΕ4 lowers energy expenditure in females and impairs glucose oxidation by increasing flux through aerobic glycolysis, Mol. Neurodegener. source
The Discussion (page unavailable) reports altered glucose metabolism in APOE4-expressing neurons and astrocytes. The Results section on single-cell sequencing also reports lower expression of mitochondrial beta-oxidation genes in E4 astrocytes, offering limited support for altered lipid metabolism. The passages do not establish dysregulated lipid homeostasis broadly, and a search for lysosomal, autophagosomal, and autophagy impairments found no supporting passage. (LLM, conf=0.86)
Experimental — accuracy not yet measured - cites [9] Qi, 2021, ApoE4 Impairs Neuron-Astrocyte Coupling of Fatty Acid Metabolism, Cell Rep. source
The Results sections on ApoE4 neurons and astrocytic fatty-acid degradation report altered glucose metabolism and lipid handling in both cell types (pages unavailable). The Results also discuss lipophagy in neuronal lipid-droplet turnover, but do not establish ApoE4-induced lysosomal or autophagosomal impairment; that part of the claim is unsupported. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [23] Wu, 2018, Human ApoE Isoforms Differentially Modulate Brain Glucose and Ketone Body Metabolism: Implications for Alzheimer’s Disease Risk Reduction and Early Intervention, J. Neurosci. source
The Abstract and Discussion report deficient glucose uptake and metabolism in ApoE4-expressing brains, and the Introduction associates ApoE4 with deregulated lipid metabolism. Our copy does not establish ApoE4-related lysosomal or autophagosomal impairment, or the full set of claimed effects in both neurons and astrocytes. (LLM, conf=0.87)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisecitation§ DiscussionHigh lactate levels were detected in the default network brain area and showed a strong correlation with the Aβ deposit area in AD brains.
“High lactate levels were detected in the brain area, the so-called default network, a set of brain areas spontaneously coactivated across time in the resting state, and showed a strong correlation with the Aβ deposit area in AD brains.32”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [32] Buckner, 2005, Molecular, Structural, and Functional Characterization of Alzheimer’s Disease: Evidence for a Relationship between Default Activity, Amyloid, and Memory, J. Neurosci. source
The section “Amyloid deposition occurs in regions active during young adult default states” reports a strong spatial correlation between default activity in young adults and amyloid deposition in older adults with AD. It does not report detecting high lactate levels or correlating lactate with amyloid deposits. Page numbers are unavailable in our copy. (LLM, conf=0.89)
Experimental — accuracy not yet measured - cites [33] van der Kant, 2020, Amyloid-β-independent regulators of tau pathology in Alzheimer disease, Nat. Rev. Neurosci. source
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitation§ DiscussionNPC identity was validated by immunostaining with anti-SOX-2 and Nestin antibodies.
“After validating the identity of NPCs by immunostaining with anti-SOX-2 and Nestin antibodies, they were further differentiated into astrocytes with Astrocyte Medium (ScienCell) as described previously.8”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [8] TCW, 2017, An Efficient Platform for Astrocyte Differentiation from Human Induced Pluripotent Stem Cells, Stem Cell Rep. source
The Experimental Procedures section on immunocytochemistry describes antibody staining generally, but does not identify SOX-2 or Nestin antibodies or say they validated NPC identity. Searches for SOX2, Nestin, and NPC validation found no such passage in our copy; the Results instead describe staining used to assess astrocyte differentiation. (LLM, conf=0.74)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisecitation§ DiscussionIn the human brain, aerobic glycolysis is associated with the neuronal developmental stage and gradually decreases with age, whereas glucose usage for mitochondrial OXPHOS is relatively sustained.
“In the human brain, aerobic glycolysis is associated with the neuronal developmental stage, which gradually decreases with age, whereas glucose usage for mitochondrial OXPHOS is relatively sustained.24”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [24] Goyal, 2017, Loss of Brain Aerobic Glycolysis in Normal Human Aging, Cell Metab. source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown data§ ResultsThe m+5 and m+6 fractions of glucose-6-phosphate and fructose-6-phosphate are significantly reduced in ApoE4 astrocytes, suggesting impaired glucose uptake.
“the m+5 and m+6 fractions of glucose-6-phosphate (Figure 1J) and fructose-6-phosphate (Figure S2A) were significantly reduced in ApoE4 astrocytes, suggesting the possibility of impaired glucose uptake”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown data§ ResultsThe fraction of m+3 lactate is increased in ApoE4 astrocytes compared with ApoE3 astrocytes, indicating enhanced aerobic glycolysis.
“We observed an increased fraction of m+3 lactate in ApoE4 astrocytes compared with that in ApoE3 astrocytes, indicating enhanced aerobic glycolysis in these cells”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown data§ ResultsGlycolytic capacity and glycolytic reserve are increased in ApoE4 astrocytes compared with ApoE3 astrocytes.
“Glycolytic capacity and glycolytic reserve, measured by sequential treatment with oligomycin and 2-deoxy-D-glucose (2-DG), were also shown to be increased in ApoE4 astrocytes”
Quote in the paperSubstantial claimMay combine two claims.
Findingown data§ ResultsApoE4 astrocytes show impaired mitochondrial respiration or reduced OXPHOS compared with ApoE3 astrocytes.
“The oxygen consumption rate assay showed a significantly reduced basal respiration rate in ApoE4 astrocytes compared with that in ApoE3 astrocytes”
- Also stated in: § 6 Send email to gotra827@kiom.re.kr ∙ In-Kyu Lee · plain
“Human ApoE4 astrocytes display increased glycolytic activity and reduced OXPHOS”
Quote in the paperSubstantial claim- Also stated in: § 6 Send email to gotra827@kiom.re.kr ∙ In-Kyu Lee · plain
May combine two claims.
Findingown data§ ResultsColocalization of lysosomes and mitochondria is significantly increased in ApoE4 astrocytes, suggesting impaired lysosome-dependent mitochondrial degradation.
“The significantly increased colocalization of lysosomes and mitochondria found in ApoE4 astrocytes was likely due to lysosomal dysfunction, suggesting impaired lysosome-dependent mitochondrial degradation in these cells”
Quote in the paperSubstantial claimMay combine two claims.
Findingown data§ ResultsApoE4 astrocytes have increased autophagosomes (RFP and GFP) and decreased autolysosomes (RFP only) compared with ApoE3 astrocytes, indicating impaired autophagy flux.
“We observed increased autophagosomes (RFP and GFP) and decreased autolysosomes (RFP only) in ApoE4 astrocytes compared with ApoE3 astrocytes, indicating impaired autophagy flux”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown data§ ResultsGlutamate treatment induces a transient increase in lactate levels in both ApoE3 and ApoE4 astrocytes.
“We observed a transient increase in lactate levels in both ApoE3 and ApoE4 astrocytes upon glutamate treatment”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown data§ ResultsThere is no difference in Aβ-induced lactate synthetic activity in ApoE4 astrocytes compared with ApoE3 astrocytes and no interaction effect between time and genotypes.
“We did not observe the difference in Aβ-induced lactate synthetic activity in ApoE4 astrocytes compared with in ApoE3 astrocytes and the interaction effect between time and genotypes”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown data§ ResultsMβCD treatment restores autolysosomes and autophagosome areas in ApoE4 astrocytes, suggesting normalized autophagy flux.
“We observed the restoration of autolysosomes and autophagosome areas in ApoE4 astrocytes with MβCD treatment, suggesting normalized autophagy flux”
Quote in the paperSubstantial claimMay combine two claims.
Findingown data§ ResultsMost transcripts of genes associated with OXPHOS are downregulated in ApoE4 astrocytes, while glycolysis genes are relatively equally up- or downregulated.
“While a relatively equal number of genes involved in glycolysis were being either up- or downregulated, the transcripts of most of the genes associated with OXPHOS were downregulated”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown data§ ResultsAβ-induced lactate synthesis tends to increase with time.
“Unlike glutamate treatment, Aβ-induced lactate synthesis tends to increase with time.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown data§ DiscussionIncreased circular forms of mitochondria in ApoE4 astrocytes observed by electron microscopy suggested accumulation of dysfunctional mitochondria.
“Finally, while increased circular forms of mitochondria in ApoE4 astrocytes observed by electron microscopy suggested accumulation of dysfunctional mitochondria, it did not provide direct evidence of ApoE4-induced perturbation of mitochondrial biogenesis or turnover and its causal relationship with metabolic abnormality.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown data§ ResultsMβCD-treated ApoE4 astrocytes display a reduced LysoTracker area comparable to ApoE3 astrocytes without disrupting plasma membrane lipid integrity.
“MβCD-treated ApoE4 astrocytes also displayed a reduced LysoTracker area in cells comparable to that in ApoE3 astrocytes without disrupting the integrity of the lipids on the plasma membrane measured by time-of-flight secondary ion mass spectrometry (ToF-SIMS)”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown data§ ResultsIn another ApoE3/ApoE4 isogenic astrocyte pair, ApoE4 astrocytes display impaired autophagy flux compared with isogenic ApoE3 cells, and this effect is attenuated by MβCD treatment.
“As shown in Figures 3L–3O, ApoE4 astrocytes displayed impaired autophagy flux compared with their isogenic ApoE3 cells, and this effect was attenuated by MβCD treatment”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ DiscussionProteomics of AD brains revealed strong upregulation of glial proteins associated with glucose metabolism.
“Proteomics of AD brains revealed strong upregulation of glial proteins associated with glucose metabolism.30”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [30] Johnson, 2020, APOE and metabolic dysfunction in Alzheimer’s disease, Int. Rev. Neurobiol. source
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone given§ DiscussionInternal mass calibration for all ToF-SIMS spectra was conducted using the peaks of CH3+, Na+, C2H3+, C3H5+, and C27H45+ for the positive mode before further analysis.
“Internal mass calibration for all the ToF-SIMS spectra was conducted using the peaks of CH3+, Na+, C2H3+, C3H5+, and C27H45+ for the positive mode before further analysis.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Interpretationcitation§ DiscussionExtracellular acidification by enhanced glycolytic activity in ApoE4 astrocytes contributes to Aβ accumulation in the brain.
“suggesting an additional contribution of extracellular acidification by enhanced glycolytic activity in ApoE4 astrocytes to Aβ accumulation in the brain.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [36] Su, 2001, Acidic pH promotes the formation of toxic fibrils from β-amyloid peptide, Brain Res. source
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone given§ DiscussionEvery batch of hiPSC-derived astrocytes was validated for resting state by treatment with immune stimuli such as polyinosinic-polycytidylic acid after serum deprivation.
“Although every batch of hiPSC-derived astrocytes was subjected to the validation of their resting state by the treatment of immune stimuli such as polyinosinic-polycytidylic acid after serum deprivation, it is still possible that early exposure of astrocytes to serum induces the changes in the transcriptome, morphology, and function compared with those from cells that never encountered serum.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ DiscussionInhibition of astrocyte-specific glycolysis or astrocyte-neuron lactate shuttles impairs long-term memory formation in mice.
“Inhibition of astrocyte-specific glycolysis or astrocyte-neuron lactate shuttles was shown to impair long-term memory formation in mice.37”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [37] Mächler, 2016, In Vivo Evidence for a Lactate Gradient from Astrocytes to Neurons, Cell Metab. source
May combine two claims.
Interpretationown data§ DiscussionApoE4 in astrocytes has detrimental effects on glucose metabolism and mitochondrial fitness, suggesting contributions of ApoE4 to AD pathogenesis and explaining the impact of ApoE4 on later stages of life.
“Taken together, our study demonstrating the detrimental effects of astrocyte ApoE4 in glucose metabolism and mitochondria fitness suggests contributions of ApoE4 in AD pathogenesis and provides an explanation of the impact of ApoE4 on later stages of life.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing), S4 (based).
Interpretationnone given§ DiscussionOther adverse effects of disrupted lysosomal function by cholesterol could indirectly lead to mitochondrial dysfunction.
“Lastly, although this study suggests that cholesterol-dependent mitophagy impairment causes mitochondrial dysfunction, it is possible that other adverse effects of disrupted lysosomal function by cholesterol could indirectly lead to mitochondrial dysfunction.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Study design and conductnone given§ DiscussionEarly exposure of astrocytes to serum may induce changes in transcriptome, morphology, and function compared with cells that never encountered serum.
“Although every batch of hiPSC-derived astrocytes was subjected to the validation of their resting state by the treatment of immune stimuli such as polyinosinic-polycytidylic acid after serum deprivation, it is still possible that early exposure of astrocytes to serum induces the changes in the transcriptome, morphology, and function compared with those from cells that never encountered serum.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ DiscussionCell number was measured with DAPI staining to normalize Seahorse values.
“At the end of the experiment, cell number was measured with DAPI staining to normalize the value using ImageXpress Micro Confocal (Molecular Devices).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone given§ DiscussionThe bleed-through from mTFP to the long-band PMT was 0.45, and from Venus to the short-band PMT was 0.02, which was ignored.
“The bleed-through from mTFP to the long-band PMT was 0.45, and from Venus to short-band PMT, it was 0.02, which was ignored.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ DiscussionAll identified proteins in the proteomic analysis had a false discovery rate of ≤1%, calculated at the peptide level.
“All identified proteins had a false discovery rate of ≤1%, which was calculated at the peptide level.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone given§ DiscussionMass spectrometer calibration was performed using the proposed calibration solution, according to the manufacturer's instructions.
“Mass spectrometer calibration was performed using the proposed calibration solution, according to the manufacturer’s instructions.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationreasoning§ DiscussionIncreased cholesterol levels could lead to lysosomal dysfunction and impaired mitochondrial homeostasis.
“which could lead to lysosomal dysfunction and impaired mitochondrial homeostasis (Figure 5K).”
Quote in the paperSubstantial claim
The paper relies on this without support.
The causal relationship between ApoE4 and altered glucose metabolism, its underlying mechanisms, and its contribution to Alzheimer's disease pathogenesis remains elusive.
“However, the causal relationship between ApoE4 and altered glucose metabolism, its underlying mechanisms, and its contribution to AD pathogenesis remains elusive.”
The paper relies on this without support.
APOE4 is one of the strongest genetic risk factors for Alzheimer's disease.
“Of the three isoforms (ε2, ε3, and ε4), ε4 (APOE4) is well known as one of the strongest genetic risk factors for AD.”
The paper relies on this without support.
Accumulation of cholesterol in cells disrupts the function of intracellular membranous compartments, including lysosomes, which are important for the homeostasis of mitochondria.
“This phenotypic abnormality is especially intriguing because the accumulation of cholesterol in cells disrupts the function of intracellular membranous compartments, including lysosomes, which are important for the homeostasis of mitochondria, essential organelles for energy metabolism.”
The authors state this as an assumption.
The half-life of mitochondria in astrocytes is unknown.
“although their half-life in astrocytes is unknown.”
The paper relies on this without support.
ApoE4 greatly increases the risk of AD and lowers the age of onset.
“ApoE4, which greatly increases the risk of AD and lowers the age of onset”
The paper relies on this without support.
FBS in astrocyte culture media makes astrocytes more proliferative.
“Because having FBS in astrocyte culture media was known to make astrocytes more proliferative”
The paper relies on this without support.
Including serum in astrocyte culture media is critical for the proliferation of cells after differentiation from hiPSCs.
“as including serum in astrocyte culture media is critical for the proliferation of cells after differentiation from hiPSCs”
The paper relies on this without support.
Astrocytes transport lactate to neurons, and it is converted to pyruvate and subsequently oxidized to produce energy in response to neuronal activity.
“Astrocytes transport lactate to neurons, and it is converted to pyruvate and subsequently oxidized to produce energy in response to neuronal activity.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
This mitochondrial dysfunction partly results from a blockade of mitophagy owing to APOE4-mediated lysosomal dysfunction, leading to accumulation of damaged and dysfunctional mitochondria in APOE4 carriers.
“in vitro studies have indicated that this mitochondrial dysfunction partly results from a blockade of mitophagy owing to APOE4-mediated lysosomal dysfunction, which leads to an accumulation of damaged and dysfunctional mitochondrial in APOE4 carriers167–169.”
From Multifaceted roles of APOE in Alzheimer disease (2024) · cites this paper as [169]
The Results and Discussion (pages unavailable) link ApoE4-related lysosomal dysfunction to impaired mitochondrial degradation and accumulation of dysfunctional mitochondria in cultured human astrocytes. The Discussion describes mitophagy impairment as a suggested mechanism and says the study did not directly establish altered mitochondrial turnover. The claim extends this finding to APOE4 carriers generally and presents a mitophagy blockade more definitively than the paper does. (LLM, conf=0.85)
Experimental — accuracy not yet measuredMitochondrial damage in astrocytes can lead to the accumulation of lipid droplets, thereby further exacerbating the pathological progression of Alzheimer's disease.
“Mitochondrial damage in astrocytes can lead to the accumulation of lipid droplets, thereby further exacerbating the pathological progression of AD [16, 17, 18].”
From Aerobic exercise improves astrocyte mitochondrial quality and transfer to neurons in a mouse model of Alzheimer's disease (2025) · cites this paper as [18]
The Introduction and Discussion report dysfunctional mitochondria in ApoE4 human astrocytes and suggest that these changes contribute to AD pathogenesis. They do not report that mitochondrial damage causes lipid-droplet accumulation or that such droplets further exacerbate AD progression; the causal pathway studied instead runs from lysosomal cholesterol accumulation to impaired removal of damaged mitochondria. No page numbers are available in our copy. (LLM, conf=0.86)
Experimental — accuracy not yet measuredThe decrease in PDH subunits and increase in PC in APOE4 iAstrocytes is consistent with a previous study.
“Surprisingly, we saw differences in these proteins including a decrease in subunits of PDH and an increase in PC in APOE4 iAstrocytes consistent with a previous study 35 .”
From APOE4-drives brain bioenergetic shifts independent of Alzheimer’s disease pathology (2026) · cites this paper as [35]
The Results (page unavailable) report enhanced aerobic glycolysis and impaired mitochondrial respiration in ApoE4 astrocytes, broadly consistent with altered glucose metabolism. They do not report decreased PDH subunits or increased PC; searches for PDH and pyruvate carboxylase found no such comparison. (LLM, conf=0.78)
Experimental — accuracy not yet measuredSome studies found that APOE4 reduced glycolysis, whereas others observed a shift from oxidative to glycolytic metabolism in APOE4 cells with higher glycolytic activity in APOE4 than APOE3.
“Some studies found that APOE4 reduced glycolysis [28,39], whereas others observed a shift from oxidative to glycolytic metabolism in APOE4 cells with higher glycolytic activity in APOE4 than APOE3 [40,41,42].”
From APOE4 Increases Energy Metabolism in APOE-Isogenic iPSC-Derived Neurons (2024) · cites this paper as [40]
These findings of decreased mitochondrial function and a switch to glycolysis are consistent with previous studies.
“These findings of decreased mitochondrial function and a switch to glycolysis is consistent with previous studies 33,35 .”
From APOE4-drives brain bioenergetic shifts independent of Alzheimer’s disease pathology (2026) · cites this paper as [35]
Many contradictory results on the impact of APOE on energy metabolism have been published.
“In general, many contradictory results on the impact of APOE on energy metabolism have been published.”
From APOE4 Increases Energy Metabolism in APOE-Isogenic iPSC-Derived Neurons (2024) · cites this paper as [40]
The Introduction describes altered metabolism in ApoE4 carriers and says its causal relationship with glucose metabolism remains elusive. The Results report findings consistent with previous studies, but the passages found do not say that many published results on APOE and energy metabolism contradict one another. I searched for contradictory or conflicting findings and comparisons with previous studies. (LLM, conf=0.73)
Experimental — accuracy not yet measured
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625 · see citing works
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197 · see citing works
Buckner, R. L., Snyder, A. Z., Shannon, B. J., LaRossa, G., Sachs, R., Fotenos, A. F., Sheline, Y. I., Klunk, W. E., Mathis, C. A., Morris, J. C., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2177-05.2005 · Cited by 2,140 · see citing works
Astrocyte-Neuron Lactate Transport Is Required for Long-Term Memory Formation
Suzuki, A., Stern, S. A., Bozdagi, O., Huntley, G. W., Walker, R. H., Magistretti, P. J., & Alberini, C. M. (2011) · Cell · doi:10.1016/j.cell.2011.02.018 · Cited by 1,711 · see citing works
Distinct patterns of brain activity in young carriers of the <i>APOE</i> -ε4 allele
Filippini, N., MacIntosh, B. J., Hough, M. G., Goodwin, G. M., Frisoni, G. B., Smith, S. M., Matthews, P. M., Beckmann, C. F., & Mackay, C. E. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811879106 · Cited by 1,613 · see citing works
Lin, Y.-T., Seo, J., Gao, F., Feldman, H. M., Wen, H.-L., Penney, J., Cam, H. P., Gjoneska, E., Raja, W. K., Cheng, J., et al. (2018) · Neuron · doi:10.1016/j.neuron.2018.05.008 · Cited by 1,125 · see citing works
Self-citationA Breakdown in Metabolic Reprogramming Causes Microglia Dysfunction in Alzheimer's Disease
Baik, S. H., Kang, S., Lee, W., Choi, H., Chung, S., Kim, J.-I., & Mook-Jung, I. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.06.005 · Cited by 843 · see citing works
Gordon, B. A., Blazey, T. M., Su, Y., Hari-Raj, A., Dincer, A., Flores, S., Christensen, J., McDade, E., Wang, G., Xiong, C., et al. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30028-0 · Cited by 602 · see citing works
Amyloid-β-independent regulators of tau pathology in Alzheimer disease
van der Kant, R., Goldstein, L. S. B., & Ossenkoppele, R. (2020) · Nature reviews. Neuroscience · doi:10.1038/s41583-019-0240-3 · Cited by 580 · see citing works
In vivo evidence for a lactate gradient from astrocytes to neurons
Mächler, P., Wyss, M. T., Elsayed, M., Stobart, J., Gutierrez, R., von Faber-Castell, A., Kaelin, V., Zuend, M., San Martín, A., Romero-Gómez, I., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.10.010 · Cited by 571 · see citing works
An Efficient Platform for Astrocyte Differentiation from Human Induced Pluripotent Stem Cells
TCW, J., Wang, M., Pimenova, A. A., Bowles, K. R., Hartley, B. J., Lacin, E., Machlovi, S. I., Abdelaal, R., Karch, C. M., Phatnani, H., et al. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.06.018 · Cited by 435 · see citing works
Cholesterol and matrisome pathways dysregulated in astrocytes and microglia
TCW, J., Qian, L., Pipalia, N. H., Chao, M. J., Liang, S. A., Shi, Y., Jain, B. R., Bertelsen, S. E., Kapoor, M., Marcora, E., et al. (2022) · Cell · doi:10.1016/j.cell.2022.05.017 · Cited by 411 · see citing works
Spatial correlation between brain aerobic glycolysis and amyloid-β (Aβ) deposition
Vlassenko, A. G., Vaishnavi, S. N., Couture, L., Sacco, D., Shannon, B. J., Mach, R. H., Morris, J. C., Raichle, M. E., & Mintun, M. A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010461107 · Cited by 404 · see citing works
ApoE4 Impairs Neuron-Astrocyte Coupling of Fatty Acid Metabolism
Qi, G., Mi, Y., Shi, X., Gu, H., Brinton, R. D., & Yin, F. (2021) · Cell Reports · doi:10.1016/j.celrep.2020.108572 · Cited by 379 · see citing works
San Martín, A., Ceballo, S., Ruminot, I., Lerchundi, R., Frommer, W. B., & Barros, L. F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057712 · Cited by 361 · see citing works
The Turnover of Mitochondria in a Variety of Tissues of Young Adult and Aged Rats
Menzies, R. A., & Gold, P. H. (1971) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)62305-1 · Cited by 336 · see citing works
Loss of Brain Aerobic Glycolysis in Normal Human Aging
Goyal, M. S., Vlassenko, A. G., Blazey, T. M., Su, Y., Couture, L. E., Durbin, T. J., Bateman, R. J., Benzinger, T. L.-S., Morris, J. C., & Raichle, M. E. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.07.010 · Cited by 318 · see citing works
Lipid accumulation induced by APOE4 impairs microglial surveillance of neuronal-network activity
Victor, M. B., Leary, N., Luna, X., Meharena, H. S., Scannail, A. N., Bozzelli, P. L., Samaan, G., Murdock, M. H., von Maydell, D., Effenberger, A. H., et al. (2022) · Cell Stem Cell · doi:10.1016/j.stem.2022.07.005 · Cited by 316 · see citing works
Lipid Accumulation Induced by APOE4 Impairs Microglial Surveillance of Neuronal-Network Activity
Victor, M. B., Leary, N., Luna, X., Meharena, H. S., Bozzelli, P. L., Samaan, G., Murdock, M. H., von Maydell, D., Effenberger, A. H., Cerit, O., et al. (2022) · doi:10.1101/2022.03.21.484146 · Cited by 311
A reference human induced pluripotent stem cell line for large-scale collaborative studies
Pantazis, C. B., Yang, A., Lara, E., McDonough, J. A., Blauwendraat, C., Peng, L., Oguro, H., Kanaujiya, J., Zou, J., Sebesta, D., et al. (2022) · Cell Stem Cell · doi:10.1016/j.stem.2022.11.004 · Cited by 310 · see citing works
Croteau, E., Castellano, C. A., Fortier, M., Bocti, C., Fulop, T., Paquet, N., & Cunnane, S. C. (2018) · Experimental Gerontology · doi:10.1016/j.exger.2017.07.004 · Cited by 258 · see citing works
REST and neural gene network dysregulation in iPSC models of Alzheimer’s disease
Meyer, K., Feldman, H. M., Lu, T., Drake, D., Lim, E. T., Ling, K.-H., Bishop, N. A., Pan, Y., Seo, J., Lin, Y.-T., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.01.023 · Cited by 216 · see citing works
Self-citationLin, Y.-T., Seo, J., Gao, F., Feldman, H. M., Wen, H.-L., Penney, J., Cam, H. P., Gjoneska, E., Raja, W. K., Cheng, J., et al. (2018) · Neuron · doi:10.1016/j.neuron.2018.06.011 · Cited by 210 · see citing works
Self-citationDavis, O. B., Shin, H. R., Lim, C.-Y., Wu, E. Y., Kukurugya, M., Maher, C. F., Perera, R. M., Ordonez, M. P., & Zoncu, R. (2021) · Developmental Cell · doi:10.1016/j.devcel.2020.11.016 · Cited by 200 · see citing works
Maetzel, D., Sarkar, S., Wang, H., Abi-Mosleh, L., Xu, P., Cheng, A. W., Gao, Q., Mitalipova, M., & Jaenisch, R. (2014) · Stem Cell Reports · doi:10.1016/j.stemcr.2014.03.014 · Cited by 195 · see citing works
Wu, L., Zhang, X., & Zhao, L. (2018) · The Journal of Neuroscience · doi:10.1523/jneurosci.2262-17.2018 · Cited by 185 · see citing works
Stress gates an astrocytic energy reservoir to impair synaptic plasticity
Murphy-Royal, C., Johnston, A. D., Boyce, A. K. J., Diaz-Castro, B., Institoris, A., Peringod, G., Zhang, O., Stout, R. F., Spray, D. C., Thompson, R. J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15778-9 · Cited by 158 · see citing works
Apolipoprotein-E (Apoe) ε4 and cognitive decline over the adult life course
Rawle, M. J., Davis, D., Bendayan, R., Wong, A., Kuh, D., & Richards, M. (2018) · Translational Psychiatry · doi:10.1038/s41398-017-0064-8 · Cited by 137 · see citing works
Acidic pH promotes the formation of toxic fibrils from β-amyloid peptide
Su, Y., & Chang, P.-T. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03322-9 · Cited by 135 · see citing works
Lee, S.-I., Jeong, W., Lim, H., Cho, S., Lee, H., Jang, Y., Cho, J., Bae, S., Lin, Y.-T., Tsai, L.-H., et al. (2021) · Stem Cell Reports · doi:10.1016/j.stemcr.2021.07.017 · Cited by 105 · see citing works
Self-citationWeise, C. M., Chen, K., Chen, Y., Kuang, X., Savage, C. R., & Reiman, E. M. (2018) · NeuroImage: Clinical · doi:10.1016/j.nicl.2018.07.016 · Cited by 96 · see citing works
Farmer, B. C., Williams, H. C., Devanney, N. A., Piron, M. A., Nation, G. K., Carter, D. J., Walsh, A. E., Khanal, R., Young, L. E. A., Kluemper, J. C., et al. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00483-y · Cited by 87 · see citing works
Cognitive and neural signatures of the APOE E4 allele in mid-aged adults
Evans, S., Dowell, N. G., Tabet, N., Tofts, P. S., King, S. L., & Rusted, J. M. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.01.145 · Cited by 86 · see citing works
Go, Y., Jeong, J. Y., Jeoung, N. H., Jeon, J., Park, B.-Y., Kang, H., Ha, C., Choi, Y., Lee, S. J., Ham, H. J., et al. (2016) · Diabetes · doi:10.2337/db16-0223 · Cited by 77 · see citing works
Self-citationKrishna, S., Arrojo e Drigo, R., Capitanio, J. S., Ramachandra, R., Ellisman, M., & Hetzer, M. W. (2021) · Developmental Cell · doi:10.1016/j.devcel.2021.10.008 · Cited by 73 · see citing works
Intracellular Cholesterol Synthesis and Transport
Shi, Q., Chen, J., Zou, X., & Tang, X. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.819281 · Cited by 73 · see citing works
Mitochondria and Cardiac Hypertrophy.
Facundo, H. D. T. F., Brainard, R. E., Caldas, F. R. D. L., & Lucas, A. M. B. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-55330-6_11 · Cited by 70 · see citing works
Carroll, C. M., & Macauley, S. L. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00258 · Cited by 32 · see citing works
Ercoli, L., Siddarth, P., Huang, S.-C., Miller, K., Bookheimer, S. Y., Wright, B. C., Phelps, M. E., & Small, G. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.4.442 · Cited by 31 · see citing works
Keum, D., Baek, C., Kim, D., Kweon, H.-J., & Suh, B. (2014) · The Journal of General Physiology · doi:10.1085/jgp.201411245 · Cited by 31 · see citing works
Self-citationAPOE and metabolic dysfunction in Alzheimer's disease
(2020) · International Review of Neurobiology · doi:10.1016/bs.irn.2020.02.002 · Cited by 31 · see citing works
Impact of Genetic Risk Factors for Alzheimer’s Disease on Brain Glucose Metabolism
Cho, S., Lee, H., & Seo, J. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02297-x · Cited by 25 · see citing works
Self-citationSwaroop, M., Thorne, N., Rao, M. S., Austin, C. P., McKew, J. C., & Zheng, W. (2012) · SLAS Discovery · doi:10.1177/1087057112456877 · Cited by 22 · see citing works
Li, R., Hao, J., Fujiwara, H., Xu, M., Yang, S., Dai, S., Long, Y., Swaroop, M., Li, C., Vu, M., et al. (2017) · ASSAY and Drug Development Technologies · doi:10.1089/adt.2017.774 · Cited by 21 · see citing works
A reference induced pluripotent stem cell line for large-scale collaborative studies
Pantazis, C., Yang, A., Lara, E., McDonough, J., Blauwendraat, C., Peng, L.-Z., Oguro, H., Kanaujiya, J., Zou, J., Sebesta, D., et al. (2021) · bioRxiv · doi:10.1101/2021.12.15.472643 · Cited by 21
APOE4 impairs neuron‐astrocyte coupling of fatty acid metabolism
Qi, G., Mi, Y., Shi, X., Gu, H., Brinton, R. D., & Yin, F. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.045251 · Cited by 19 · see citing works
Neuromyelitis optica (NMO)‐IgG‐driven organelle reorganization in human iPSC‐derived astrocytes
Cho, S., Lee, H. G., Jung, M., Hong, K., Woo, S., Lee, Y., Kim, B. J., Jeon, M. Y., Seo, J., & Mun, J. Y. (2021) · The FASEB Journal · doi:10.1096/fj.202100637r · Cited by 9 · see citing works
Self-citationLim, H., Lee, S. Y., Moon, D. W., & Kim, J. Y. (2019) · RSC Advances · doi:10.1039/c9ra05205d · Cited by 7 · see citing works
Self-citationFarmer, B. C., Williams, H. C., Devanney, N., Piron, M. A., Nation, G. K., Carter, D. J., Walsh, A. E., Khanal, R., Young, L. E. A., Kluemper, J. C., et al. (2020) · doi:10.1101/2020.10.19.345991
Davis, O. B., Shin, H. R., Lim, C.-Y., Wu, E. Y., Kukurugya, M., Maher, C. F., Perera, R. M., Ordonez, M. P., & Zoncu, R. (2020) · doi:10.1101/2020.08.02.233254
Flagged first, then by citations
Cited by
Sorted by citations
Cell type‐specific roles of APOE4 in Alzheimer disease
Blumenfeld, J., Yip, O., Kim, M. J., & Huang, Y. (2024) · Nature Reviews Neuroscience · doi:10.1038/s41583-023-00776-9 · Cited by 202 · see citing works
Self-citationMultifaceted roles of APOE in Alzheimer disease
Jackson, R. J., Hyman, B. T., & Serrano-Pozo, A. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-024-00988-2 · Cited by 193 · see citing works
The Glutamate/ GABA ‐Glutamine Cycle: Insights, Updates, and Advances
Andersen, J. V. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70029 · Cited by 156 · see citing works
Liu, T., Kong, X., Qiao, J., & Wei, J. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103787 · Cited by 108 · see citing works
Pathological mechanisms and treatment progression of Alzheimer’s disease
Zhang, J., Kong, G., Yang, J., Pang, L., & Li, X. (2025) · European journal of medical research · doi:10.1186/s40001-025-02886-9 · Cited by 94 · see citing works
Mitochondria in Alzheimer’s Disease Pathogenesis
Reiss, A. B., Gulkarov, S., Jacob, B., Srivastava, A., Pinkhasov, A., Gomolin, I. H., Stecker, M. M., Wısnıewskı, T., & Leon, J. D. (2024) · Life · doi:10.3390/life14020196 · Cited by 62 · see citing works
Chen, Y., Jin, H., Chen, J., Li, J., Găman, M., & Zou, Z. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02600-y · Cited by 52 · see citing works
Lysosomal acidification impairment in astrocyte-mediated neuroinflammation
Zeng, J., Indajang, J., Pitt, D., & Lo, C. H. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03410-w · Cited by 38 · see citing works
Lu, J., Wu, K., Sha, X., Lin, J., Chen, H., & Yu, Z. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00445-6 · Cited by 31 · see citing works
Cai, J., Chen, Y., She, Y., He, X., Feng, H., Sun, H., Yin, M., Gao, J., Sheng, C., Li, Q., et al. (2025) · Brain Pathology · doi:10.1111/bpa.13316 · Cited by 30 · see citing works
Ye, J., Zhong, S., Wan, H., Guo, X., Yao, X., Liu, Q., Chen, L., Wang, J., & Xiao, S. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00796-2 · Cited by 30 · see citing works
Failure of lysosomal acidification and endomembrane network in neurodegeneration
Kim, S.-H., Cho, Y.-S., & Jung, Y. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01579-x · Cited by 29 · see citing works
Du, L., Fang, C., Wang, Y., Feng, Z., Abiola, O. F., Gao, Z., Huang, J., & Ma, Y. (2025) · Acta Pharmacologica Sinica · doi:10.1038/s41401-025-01505-x · Cited by 27 · see citing works
Astrocyte priming enhances microglial Aβ clearance and is compromised by APOE4
Lee, S. J., Yu, J. J., Lee, H. G., Kim, B., Jang, M. J., Jo, H., Kim, N. Y., Pak, M. E., Kim, J. K., Cho, S., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-62995-1 · Cited by 27 · see citing works
Self-citationChen, J., Zhao, S., Zhou, Y., Wang, L., Chen, Q., & Zheng, K. (2025) · BioScience Trends · doi:10.5582/bst.2025.01148 · Cited by 27 · see citing works
Hellén, M., Weert, I., Müller, S. A., Räsänen, N., Kettunen, P., Lehtonen, Š., Peitz, M., Fließbach, K., Takalo, M., Koskuvi, M., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03470-y · Cited by 25 · see citing works
Budny, V., Ruminot, I., Wybitul, M., Treyer, V., Barros, L. F., & Tackenberg, C. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03550-w · Cited by 25 · see citing works
Ding, Y., Palecek, S. P., & Shusta, E. V. (2024) · Fluids and Barriers of the CNS · doi:10.1186/s12987-024-00580-2 · Cited by 22 · see citing works
Gręda, A., Gomes, J. P., Schmidt, V., Żurawska-Płaksej, E., Fritsche‐Guenther, R., Rudolph, I., Telugu, N. S., Cömert, C., Kirwan, J., Kunz, S., et al. (2025) · Nature Metabolism · doi:10.1038/s42255-025-01389-5 · Cited by 21 · see citing works
Lysosomal proteomics reveals mechanisms of neuronal APOE4-associated lysosomal dysfunction
Krogsaeter, E., McKetney, J., Valiente‐Banuet, L., Marquez, A., Willis, A., Cakir, Z., Stevenson, E. J., Jang, G. Μ., Rao, A. T., Li, E., et al. (2025) · Autophagy · doi:10.1080/15548627.2025.2576613 · Cited by 22 · see citing works
New insights into innate immunity in Alzheimer’s disease: From APOE protective variants to therapies
Chen, Y., & Holtzman, D. M. (2024) · Trends in Immunology · doi:10.1016/j.it.2024.08.001 · Cited by 19 · see citing works
Zhang, W.-X., Yang, Y.-L., Yu, J., Jia, L., & Huang, H. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.152335 · Cited by 17 · see citing works
Recognizing Alzheimer's disease from perspective of oligodendrocytes: Phenomena or pathogenesis?
Wang, J., Zhen, Y., Yang, J., Yang, S., & Zhu, G. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14688 · Cited by 16 · see citing works
Bioenergetics and lipid metabolism in Alzheimer's disease: From cell biology to systemic health
Maioli, S., Nalvarte, I., Ankarcrona, M., Schultzberg, M., Zuloaga, K. L., Goikolea, J., Visser, P. J., Strooper, B. D., Winblad, B., Pizzo, P., et al. (2025) · Journal of Internal Medicine · doi:10.1111/joim.70036 · Cited by 18 · see citing works
APOE4 Increases Energy Metabolism in APOE-Isogenic iPSC-Derived Neurons
Budny, V., Knöpfli, Y., Meier, D., Zürcher, K., Bodenmann, C., Peter, S. L., Müller, T., Tardy, M., Cortijo, C., & Tackenberg, C. (2024) · Cells · doi:10.3390/cells13141207 · Cited by 15 · see citing works
Hu, J., Zhu, Z., Zhang, Z., Hu, H., & Yang, Q. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122722 · Cited by 13 · see citing works
Cáceres-Palomo, L., Sánchez‐Mejías, E., Trujillo‐Estrada, L., Pérez-Moreno, J. J., Lopez-Oliva, E., Lim, T. E., DeFlitch, L., Chang, S. H., Kampman, L., Corces, M. R., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03607-z · Cited by 11 · see citing works
APOE4 drives widespread changes to the hepatic proteome and alters metabolic function
Lysaker, C. R., Johnson, C. N., Csikós, V., Franczak, E., Tetlow, A. L., Benson, M. N., Thyfault, J. P., Geiger, P. C., Morris, J. K., & Wilkins, H. (2026) · iScience · doi:10.1016/j.isci.2026.115035 · Cited by 9 · see citing works
Regulation of adult neurogenesis: the crucial role of astrocytic mitochondria
Liu, D., Guo, P., Wang, Y., & Li, W. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2024.1516119 · Cited by 8 · see citing works
Lee, J. H., Chang, W. S., Min, S. S., Song, D., & Yoo, H. (2025) · Cells · doi:10.3390/cells14171342 · Cited by 8 · see citing works
Self-citationApolipoprotein E4 in Alzheimer’s Disease: Role in Pathology, Lipid Metabolism, and Drug Treatment
Al-Ghraiybah, N. F., Alkhalifa, A. E., Itokazu, Y., Farr, T., Pérez, N., Ali, H., & Kaddoumi, A. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27021004 · Cited by 8 · see citing works
Lysaker, C. R., Johnson, C. N., Csikós, V., Franczak, E., Benson, M. N., Gilmore, C. A., Birky, C. J., Davis, X. C., McCoin, C. S., Smith, K. P., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.15.659811 · Cited by 8 · see citing works
Ashim, J., Ji, S., Kim, H.-Y., Lee, S.-W., Jang, S., Kim, W., Han, S., Kim, C., Park, S., Park, J., et al. (2025) · Environmental Science & Technology · doi:10.1021/acs.est.5c04146 · Cited by 7 · see citing works
Self-citationLucassen, P. J., Kőrösi, A., de Rooij, S. R., Smit, A. B., van Dam, A., Daskalakis, N. P., van Kesteren, R. E., Verheijen, M. H. G., Lesuis, S. L., Kessels, H. W. H. G., et al. (2024) · Biological Psychiatry · doi:10.1016/j.biopsych.2024.11.007 · Cited by 9 · see citing works
Huynh, T. N. T., Fikse, E. N., Torre, A. L. D. L., Havrda, M. C., Chang, C. C. Y., & Chang, T. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413690 · Cited by 9 · see citing works
Sheng, J., Zhang, X., Liang, W., Lyu, J., Zhang, B., Min, J., Xu, A., Xu, X., Li, J. W., Li, J., et al. (2025) · BMC Biology · doi:10.1186/s12915-025-02175-1 · Cited by 6 · see citing works
Maurya, S. K., Borgonovo, J. E., Biswal, S., Martínez‐Cerdeño, V., Mishra, R., & Muñoz, E. M. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1442322 · Cited by 7 · see citing works
APOE genotype-dependent differences in human astrocytic energy metabolism
Budny, V., Bodenmann, C., Zürcher, K. J., Krüger, M., de Leeuw, S. M., Weber, R. Z., Rust, R., Ravotto, L., Ruminot, I., Barros, L. F., et al. (2025) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2025.1603657 · Cited by 6 · see citing works
Zuniga, N. R., Earls, N. E., Denos, A. E. A., Elison, J. M., Jones, B. S., Smith, E. G., Moran, N. G., Broce, K. L., Romero, G. M., Hyer, C. D., et al. (2024) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1012407 · Cited by 6 · see citing works
Yao, Z., Godje, I. S. G., Jiao, B., Shen, L., & Luo, S. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103153 · Cited by 6 · see citing works
Comparative gene regulatory networks modulating APOE expression in microglia and astrocytesPreprint
Brase, L., Yu, Y., McDade, E., Dominantly Inherited Alzheimer Network (DIAN), Harari, O., & Benítez, B. A. (2024) · medRxiv · doi:10.1101/2024.04.19.24306098 · Cited by 6 · see citing works
Microglia-derived APOE2 improves remyelination even in the presence of endogenous APOE4
Nolt, G. L., Golden, L. R., Thorpe, S. P., Funnell, J. L., Stephens, I. O., Hernandez, G., MacLean, S. M., Lucido, C. C., Brock, C. R., Pallerla, A. V., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03639-5 · Cited by 5 · see citing works
Morgan, R. K., Tapaswi, A., Polemi, K. M., Tolrud, E. C., Bakulski, K. M., Svoboda, L. K., Dolinoy, D. C., & Colacino, J. A. (2025) · Toxicological Sciences · doi:10.1093/toxsci/kfaf072 · Cited by 5 · see citing works
Trudel, L., Therriault, J., Macedo, A. C., Woo, M. S., Rahmouni, N., Aumont, É., Servaes, S., Hosseini, S. A., Ferrari‐Souza, J. P., Bellaver, B., et al. (2025) · Communications Medicine · doi:10.1038/s43856-025-01171-4 · Cited by 5 · see citing works
Emerging roles of astrocytes in hippocampal circuitry and behavior
Squires, A., & Park, J. (2025) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2025.1694643 · Cited by 4 · see citing works
Mesentier-Louro, L. A., Goldman, C., Gaese, S., Buonfiglioli, A., Kyriakis, D., Harlock, A., Ndayisaba, A., Sartori, E. R., Uchitelev, A., Fullard, J. F., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.09.637107 · Cited by 4 · see citing works
Richards, S. E. V., Yang, M., Deik, A. A., & Ricq, E. L. (2025) · Neurochemical Research · doi:10.1007/s11064-025-04463-2 · Cited by 3 · see citing works
Neuronal endolysosomal alterations induced by Apolipoprotein E4 emerge over time in primary neurons
Nyberg, E., Konings, S. C., Lindblom, N., Israelsson, B., Klementieva, O. L., Martinsson, I., & Gouras, G. K. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.110479 · Cited by 3 · see citing works
Extracellular Vesicles in Alzheimer’s Disease: Mechanisms, Biomarkers, and Therapeutic Engineering
Wang, L., Mao, L., & Zong, X. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27093974 · Cited by 4 · see citing works
Free-water imaging of the nucleus basalis of Meynert in apolipoprotein E4 carriers
Ofori, E., Braden, B. B., Chen, K., Su, Y., Caselli, R. J., & Reiman, E. M. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1597127 · Cited by 2 · see citing works
Zeng, B., Ma, C., Zhang, S., Qiu, J., Chen, Y., Zhang, N., Cao, Q., Wang, Y., Chi, Z., Wu, Q., et al. (2025) · Lipids in Health and Disease · doi:10.1186/s12944-025-02842-w · Cited by 2 · see citing works
APOE4 drives maladaptive heterogeneity and immunometabolic responses of astrocytes
Lee, S., Williams, H. C., Gorman, A. A., Devanney, N. A., Harrison, D. A., Walsh, A. E., Goulding, D. S., Tuck, T., Schwartz, J. L., Zajac, D. J., et al. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03698-2 · Cited by 8 · see citing works
Wang, M., Niu, D.-C., Zhang, Q., Tang, Y.-Q., Zhao, Y., & Chen, F. (2026) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2026.151352 · Cited by 1 · see citing works
Amyloid-β clearance: an astrocytic perspective
Li, J., Lv, Z., Chen, X. P., Fu, F., Yang, K., Lai, G., Wu, H., & Xie, G. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1812081 · Cited by 3 · see citing works
Han, S., Zou, Q., Fang, Y., Zhang, J., Su, Y., Xie, S., Yang, Z., Zhao, Y., Li, N., Wan, W., et al. (2026) · iScience · doi:10.1016/j.isci.2026.116074 · Cited by 2 · see citing works
Yao, M., Liu, A., Song, J., Xing, L., Zi, M., & Li, H. (2026) · Neuroscience · doi:10.1016/j.neuroscience.2026.06.001 · Cited by 2 · see citing works
Zou, M., Zhao, T., Wu, W., Zhang, J. Y., Pan, P., Yan, J., Li, Q., & Zhou, Y. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03946-5 · Cited by 2 · see citing works
Cholesterol dysregulation in APOE4 astrocytes promotes α-synuclein pathology in miBrains
Mesentier-Louro, L. A., Goldman, C., Gaese, S., Buonfiglioli, A., Kyriakis, D., Harlock, A., Ndayisaba, A., Sartori, E. R., Uchitelev, A., Fullard, J. F., et al. (2026) · Cell stem cell · doi:10.1016/j.stem.2026.08.001 · Cited by 6 · see citing works
Re-energising the brain: glucose metabolism, Tau protein and memory in ageing and dementia
Robbins, M. (2024) · Ageing and Neurodegenerative Diseases · doi:10.20517/and.2023.57 · Cited by 3 · see citing works
Battaglia, R. A., Bolshakova, S., Mazureac, I., Liyanage, D., Pettinari, N. L., Johnson, A., Crouse, E., Habib, S., Flessas, I., Nadig, A., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.08.687374 · Cited by 3 · see citing works
APOE4-drives brain bioenergetic shifts independent of Alzheimer’s disease pathology
Lysaker, C. R., Johnson, C. N., Csikos, V., Franczak, E., Benson, M., Gilmore, C. A., Birky, C. J., Davis, X., McCoin, C. S., Smith, K. P., et al. (2026) · npj Dementia · doi:10.1038/s44400-026-00105-8 · Cited by 1 · see citing works
Fang, C., Huang, X., Wang, Q., Fei, Y., Wang, X. L., Zheng, Y., Xiao, Q., Gan, Z., Wang, T., & Xiong, L. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.123922 · Cited by 1 · see citing works
Cao, H., Liang, J., Dong, X., Xia, Z., Luo, X., & Liu, B. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1767811 · Cited by 1 · see citing works
Lysosomal dysfunction in diabetes and diabetic complications
Chen, X., Huang, L., Xiao, Z., & Liu, L. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1794600 · Cited by 1 · see citing works
Zhang, Z., Wang, K., Wang, L., Li, W., Guo, H., Xu, M., Wang, T., Ren, J. F., Zhu, T., Wang, J., et al. (2026) · Interdisciplinary medicine · doi:10.1002/inmd.70156 · Cited by 1 · see citing works
Lysosomal dysfunction in neurodegenerative disease
Brooker, S. M., Coukos, R., & Krainc, D. (2026) · Nature Reviews Neurology · doi:10.1038/s41582-026-01262-3 · Cited by 1 · see citing works
Link Between Obsessive-Compulsive Disorder and ApoE Gene Polymorphisms[Letter]
Xu, L., & Mei, C. (2024) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s496690 · Cited by 1 · see citing works
APOE4 disrupts the central dogma by arresting neuronal proteome dynamicsPreprint
Krogsaeter, E., McKetney, J., Li, L., Liu, I., Richards, A., Subramanyam, V., Yin, K., Gordon, M., Mairal, P. B., Stevenson, E. J., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.15.738801 · Cited by 1 · see citing works
Lee, S., Munoz-Oreja, M., Villar-Fernandez, M., Goicoechea-Barrenechea, L., Fernandez-Pelayo, U., Perez-Rodriguez, D., Gegg, M., de Arbina, A. L., Spinazzola, A., & Holt, I. J. (2026) · doi:10.64898/2026.08.04.742391
Self-citationLee, S., Son, H. J., Seo, S. W., Na, D. L., & Kim, H. J. (2024) · Precision and Future Medicine · doi:10.23838/pfm.2024.00086
Self-citationAmyloid, Tau, and ApoE: Revisiting Hypotheses of Alzheimer's Disease
Yao, B., Kuang, M., Jiang, D. F., & Xu, C. (2025) · Theoretical and Natural Science · doi:10.54254/2753-8818/2024.19396
Hellén, M., Weert, I., Müller, S. A., Lehtonen, Š., Peitz, M., Fließbach, K., Takalo, M., Koskuvi, M., Lichtenthaler, S. F., Leinonen, V., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-6241569/v1
Autophagy: A Major Regulatory Factor in Glucose Metabolism
Liu, M., Luo, X., Hu, H., & Chen, L. (2025) · Health and Metabolism · doi:10.53941/hm.2025.100024
APOE4 promotes nigral tau hyperphosphorylation through cholesterol in atherosclerosis
Hu, S., Peng, X., Xia, B., Gu, C., Sun, B., Chang, M., Ding, J., & Peng, L. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02778-1
Haddad, Y. H., Rom, Y. A., Green, G. S., Cain, A., Raveh, B., & Habib, N. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.15.694345
ApoE and Bioenergetic Signaling
Raffaı̈, R. L. (2026) · Springer eBooks · doi:10.1007/978-3-031-52641-1_70-1
Chung, J., Ko, J. W., & Kwon, Y. H. (2026) · Food and Chemical Toxicology · doi:10.1016/j.fct.2026.116106
ApoE and Bioenergetic Signaling
Raffaı̈, R. L. (2026) · Springer eBooks · doi:10.1007/978-3-031-96089-5_70
APOE4 and INPP5D converge on membrane mechanics to regulate endocytosis in human astrocytesPreprint
Gevorgyan, A. S., Gordon, L. M., Combs, C. A., Lita, A., Yang, L. G., Cuní‐López, C., Root, J. T., Larion, M., Taraska, J. W., & Narayan, P. S. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.22.726347
Frosina, M., Maurotti, S., Castagna, A., Montalcini, T., Pujia, A., & Tirinato, L. (2026) · MedComm · doi:10.1002/mco2.70789
郭, 可. (2026) · Advances in Clinical Medicine · doi:10.12677/acm.2026.1662290
Mechanisms of autophagy–lysosome pathway impairment in Alzheimer's disease
Lü, K., Lu, Y., Tang, R., Dong, X., Zhuang, P., Gao, Y., Cheng, M., Wang, Y., & Wang, Y. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261460879
Wang, M., Zhang, Z.-Y., Sha, Z., Zhang, F.-F., & Bao, K. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1808059
Xie, M., Wu, S., Yang, L., & Zhang, Y. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1895597
Chen, H., & Cui, D. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1863307
Wu, Y., Cho, G., & Lim, Y. (2026) · Biomolecules · doi:10.3390/biom16091257
APOE4 astrocytes call the shots on neuronal α-synuclein pathology
West, N. R., & Julia, T. C. W. (2026) · Cell stem cell · doi:10.1016/j.stem.2026.08.007
Autophagy-lysosomal pathway in neurodegeneration
McDonough, S. R., Rao, A. K., McAleer, J. M., Babrowicz, B. M., & Sharma, M. (2026) · Molecular Neurodegeneration Advances · doi:10.1186/s44477-026-00041-0
Zhang, L., Chen, P., Xu, N., Chen, J., Yin, Y., Liu, W., Li, L., Yu, Y., Lu, W., & Zang, P. (2026) · Biomolecules · doi:10.3390/biom16091342
Dynamic contributions of astrocytes in Alzheimer’s disease
Guo, F., Li, T., & He, X. (2026) · Experimental Neurology · doi:10.1016/j.expneurol.2026.116032
Gao, F., Lin, W., Jiao, X., Zhang, Y., Zhao, T., Zhang, J., Pei, D., 邸多隆, Yang, L., & Hai, J. (2026) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2026.140937
Esmaeili, H., Das, S., Rytel, K., Sidransky, E., & Chen, Y. (2026) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2026.110265
Glial lipid reprogramming in brain aging: Lipid identity, organelle stress, and redox vulnerability
Rana, M., Ko, W., Nepali, K., Ko, C.-Y., Yen, T., Jan, J., Taliyan, R., Li, C.-H., & Yang, C. (2026) · Redox Biology · doi:10.1016/j.redox.2026.104453
- Authors
- Lee, H., Cho, S., Kim, M.-J., Park, Y. J., Cho, E., Jo, Y. S., Kim, Y.-S., Lee, J. Y., Thoudam, T., Woo, S.-H., Lee, S.-I., Jeon, J., Lee, Y.-S., Suh, B.-C., Yoon, J. H., Go, Y., Lee, I.-K., & Seo, J.
- Affiliations
- Daegu Gyeongbuk Institute of Science and Technology (KR)
- Kyungpook National University (KR)
- Korea Institute of Oriental Medicine (KR)
- Korea Brain Research Institute (KR)
- Corresponding author
- Go, Younghoon
- Lee, In-Kyu
- Seo, Jinsoo
- ORCID
- Venue
- Cell Reports
- Publisher
- Elsevier BV
- Published
- 2023-10
- Volume
- 42
- Issue
- 10
- Pages
- 113183
- ISSN
- 2211-1247 (ISSN-L)
- OpenAlex
- W4387207575
- Cited by
- 93
- References
- 45
- Citations by year
- 2026: 36 · 2025: 38 · 2024: 19
- FWCI
- 16.40
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cell Reports (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Korea Health Industry Development Institute
- Korea Institute of Oriental Medicine (KSN2022230)
- Massachusetts Institute of Technology
- National Research Foundation of Korea (2018M3C7A1056275, 2022R1A2B5B03001929)
- Korea Brain Research Institute
- Daegu Gyeongbuk Institute of Science and Technology (22-CoE-BT-01)
- Ministry of Health and Welfare (21-BR-03-02, HU21C0111)
- Ministry of Science, ICT and Future Planning (22-BR-02-03)
- Topics
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Epidemiology › Autophagy in Disease and Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Keywords
- APOE ε4, lysosomal cholesterol accumulation, astrocytes, mitochondrial homeostasis, oxidative phosphorylation, autophagy, mitochondrial respiration, mitochondrial dynamics, glycolysis, cholesterol depletion, Alzheimer's disease, induced pluripotent stem cell-derived astrocytes
- MeSH terms
- Alzheimer Disease, Apolipoproteins E, Astrocytes, Cells, Cultured, Cholesterol, Humans, Oxidative Phosphorylation, Apolipoprotein E3, Apolipoprotein E4, Induced Pluripotent Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-11-02.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-11-02.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review